BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1365106	CC(C)(C)COc1ccn(n1)-c1ccc2c(n1)N1CC(CC1(C)C)CCNc1cccc(n1)S(=O)(=O)NC2=O	InChI=1S/C27H35N7O4S/c1-26(2,3)17-38-22-12-14-34(31-22)21-10-9-19-24(30-21)33-16-18(15-27(33,4)5)11-13-28-20-7-6-8-23(29-20)39(36,37)32-25(19)35/h6-10,12,14,18H,11,13,15-17H2,1-5H3,(H,28,29)(H,32,35)	LUXWWLDMOJEUSG-UHFFFAOYSA-N	644589	US11866450, Compound 1::Preparation of 11-[3-(2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-7,7-dimethyl-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.15,8.09,14]tricosa-1(21),9(14),10,12,18(22),19-hexaene-15,17,17-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644589	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644589&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400014	490946921							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365107	CC(C)(C)COc1ccn(n1)-c1ccc2c(n1)N1C[C@@H](CC1(C)C)CCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C27H35N7O4S/c1-26(2,3)17-38-22-12-14-34(31-22)21-10-9-19-24(30-21)33-16-18(15-27(33,4)5)11-13-28-20-7-6-8-23(29-20)39(36,37)32-25(19)35/h6-10,12,14,18H,11,13,15-17H2,1-5H3,(H,28,29)(H,32,35)	LUXWWLDMOJEUSG-UHFFFAOYSA-N	644590	US11866450, Compound 3::US11866450, Compound 2	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644590	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644590&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400156	490946922							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365108	CC(C)(C)COc1ccn(n1)-c1ccc2c(n1)N1C[C@@H](CC1(C)C)CCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C27H35N7O4S/c1-26(2,3)17-38-22-12-14-34(31-22)21-10-9-19-24(30-21)33-16-18(15-27(33,4)5)11-13-28-20-7-6-8-23(29-20)39(36,37)32-25(19)35/h6-10,12,14,18H,11,13,15-17H2,1-5H3,(H,28,29)(H,32,35)	LUXWWLDMOJEUSG-UHFFFAOYSA-N	644590	US11866450, Compound 3::US11866450, Compound 2	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644590	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644590&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400156	490946922							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365109	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C27H30F3N7O4S/c1-25(2)14-17-8-12-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)36(25)15-17)37-13-9-21(34-37)41-16-26(10-11-26)27(28,29)30/h3-7,9,13,17H,8,10-12,14-16H2,1-2H3,(H,31,32)(H,35,38)	KAHSQZGTJWJIRL-UHFFFAOYSA-N	644592	US11866450, Compound 4::Preparation of 7,7-dimethyl-11-(3-{[1-(trifluoromethyl)cyclopropyl]methoxy}-1H-pyrazol-1-yl)-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.1(5,8).0(9,14)]tricosa-1(21),9(14),10,12,18(22),19-hexaene-15,17,17-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644592	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644592&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139389562	490946923							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365110	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H30F3N7O4S/c1-25(2)14-17-8-12-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)36(25)15-17)37-13-9-21(34-37)41-16-26(10-11-26)27(28,29)30/h3-7,9,13,17H,8,10-12,14-16H2,1-2H3,(H,31,32)(H,35,38)	KAHSQZGTJWJIRL-UHFFFAOYSA-N	644593	US11866450, Compound 6::US11866450, Compound 5	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644593	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644593&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400136	490946924							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365111	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H30F3N7O4S/c1-25(2)14-17-8-12-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)36(25)15-17)37-13-9-21(34-37)41-16-26(10-11-26)27(28,29)30/h3-7,9,13,17H,8,10-12,14-16H2,1-2H3,(H,31,32)(H,35,38)	KAHSQZGTJWJIRL-UHFFFAOYSA-N	644593	US11866450, Compound 6::US11866450, Compound 5	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644593	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644593&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400136	490946924							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365112	CC1(C)CC[C@H]2CCCOc3cccc(c3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H34F3N5O5S/c1-28(2)12-10-20-5-4-17-42-21-6-3-7-22(19-21)44(40,41)36-27(39)23-8-9-24(34-26(23)38(20)28)37-16-11-25(35-37)43-18-15-29(13-14-29)30(31,32)33/h3,6-9,11,16,19-20H,4-5,10,12-15,17-18H2,1-2H3,(H,36,39)	OJWOEXUYCQOQDS-UHFFFAOYSA-N	644595	US11866450, Compound 8::US11866450, Compound 7	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644595	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644595&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400134	490946925							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365113	CC1(C)CC[C@H]2CCCOc3cccc(c3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H34F3N5O5S/c1-28(2)12-10-20-5-4-17-42-21-6-3-7-22(19-21)44(40,41)36-27(39)23-8-9-24(34-26(23)38(20)28)37-16-11-25(35-37)43-18-15-29(13-14-29)30(31,32)33/h3,6-9,11,16,19-20H,4-5,10,12-15,17-18H2,1-2H3,(H,36,39)	OJWOEXUYCQOQDS-UHFFFAOYSA-N	644595	US11866450, Compound 8::US11866450, Compound 7	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644595	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644595&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400134	490946925							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365114	CN1CCCC2CCC(C)(C)N2c2nc(ccc2C(=O)NS(=O)(=O)c2cccc1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H36F3N7O4S/c1-28(2)13-11-20-6-5-17-38(3)22-7-4-8-25(34-22)45(42,43)37-27(41)21-9-10-23(35-26(21)40(20)28)39-18-12-24(36-39)44-19-16-29(14-15-29)30(31,32)33/h4,7-10,12,18,20H,5-6,11,13-17,19H2,1-3H3,(H,37,41)	URRRUCZLZHRNNI-UHFFFAOYSA-N	644597	US11866450, Compound 9::Preparation of 12,12,19-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644597	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644597&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399747	490946926							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365115	CN1CCC[C@H]2CCC(C)(C)N2c2nc(ccc2C(=O)NS(=O)(=O)c2cccc1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)13-11-20-6-5-17-38(3)22-7-4-8-25(34-22)45(42,43)37-27(41)21-9-10-23(35-26(21)40(20)28)39-18-12-24(36-39)44-19-16-29(14-15-29)30(31,32)33/h4,7-10,12,18,20H,5-6,11,13-17,19H2,1-3H3,(H,37,41)	URRRUCZLZHRNNI-UHFFFAOYSA-N	644598	US11866450, Compound 10	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644598	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644598&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399765	490946927							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365116	CN1CCC[C@@H]2CCC(C)(C)N2c2nc(ccc2C(=O)NS(=O)(=O)c2cccc1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)13-11-20-6-5-17-38(3)22-7-4-8-25(34-22)45(42,43)37-27(41)21-9-10-23(35-26(21)40(20)28)39-18-12-24(36-39)44-19-16-29(14-15-29)30(31,32)33/h4,7-10,12,18,20H,5-6,11,13-17,19H2,1-3H3,(H,37,41)	URRRUCZLZHRNNI-UHFFFAOYSA-N	644599	US11866450, Compound 11::Preparation of (15S)-12,12,19-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(24),5(10),6,8,20,22-hexaene-2,2,4-trione (Compound 10) and (15R)-12,12,19-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(24),5(10),6,8,20,22-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644599	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644599&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399734	490946928							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365117	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-5-4-14-33-21-6-3-7-24(34-21)44(41,42)37-26(40)20-8-9-22(35-25(20)38(27)18-19)39-15-10-23(36-39)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,33,34)(H,37,40)	QKQSFYZLRINXHO-UHFFFAOYSA-N	644600	US11866450, Compound 12::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644600	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644600&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399749	490946929							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365118	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-5-4-14-33-21-6-3-7-24(34-21)44(41,42)37-26(40)20-8-9-22(35-25(20)38(27)18-19)39-15-10-23(36-39)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,33,34)(H,37,40)	QKQSFYZLRINXHO-UHFFFAOYSA-N	644601	US11866450, Compound 13	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644601	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644601&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399750	490946930							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365119	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-5-4-14-33-21-6-3-7-24(34-21)44(41,42)37-26(40)20-8-9-22(35-25(20)38(27)18-19)39-15-10-23(36-39)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,33,34)(H,37,40)	QKQSFYZLRINXHO-UHFFFAOYSA-N	644602	US11866450, Compound 14::Preparation of (14R)-12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione (Compound 13) and (14S)-12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644602&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399754	490946931							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365120	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N7O4S/c1-26(2)15-18-5-4-13-32-20-6-3-7-23(33-20)43(40,41)36-25(39)19-8-9-21(34-24(19)37(26)16-18)38-14-10-22(35-38)42-17-27(11-12-27)28(29,30)31/h3,6-10,14,18H,4-5,11-13,15-17H2,1-2H3,(H,32,33)(H,36,39)	DVFIQJYZFUHWRT-UHFFFAOYSA-N	644603	US11866450, Compound 15::Preparation of 12,12-dimethyl-8-(3-{[1-(trifluoromethyl)cyclopropyl]methoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644603&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399727	490946932							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365121	CC1(C)CCC2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N7O4S/c1-27(2)12-10-19-5-4-16-33-21-6-3-7-24(34-21)44(41,42)37-26(40)20-8-9-22(35-25(20)39(19)27)38-17-11-23(36-38)43-18-15-28(13-14-28)29(30,31)32/h3,6-9,11,17,19H,4-5,10,12-16,18H2,1-2H3,(H,33,34)(H,37,40)	MGFSKIVOBYFKPF-UHFFFAOYSA-N	644604	US11866450, Compound 16::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644604	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644604&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400053	490946933							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365122	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C27H30F3N7O4S/c1-25(2)14-17-15-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)36(25)16-17)37-12-8-21(34-37)41-13-11-26(9-10-26)27(28,29)30/h3-8,12,17H,9-11,13-16H2,1-2H3,(H,31,32)(H,35,38)	CQZHZNFUSSNRAW-UHFFFAOYSA-N	644605	US11866450, Compound 17::Preparation of 6,6-dimethyl-10-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-16&#955;6-thia-2,7,9,15,21-pentaazatetracyclo[15.3.1.14,7.08,13]docosa-1(20),8,10,12,17(21),18-hexaene-14,16,16-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644605	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644605&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400054	490946934							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365123	Cc1c2cnn1CCCC1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H34F3N7O4S/c1-18-21-16-32-37(18)12-4-5-19-15-26(2,3)36(17-19)24-20(25(39)35-43(21,40)41)6-7-22(33-24)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,19H,4-5,9-12,14-15,17H2,1-3H3,(H,35,39)	QRPXQWNLWOTVOE-UHFFFAOYSA-N	644606	US11866450, Compound 18	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644606	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644606&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400196	490946935							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365124	Cc1nn2CCCC3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3	InChI=1S/C28H34F3N7O4S/c1-18-21-17-36(33-18)12-4-5-19-15-26(2,3)37(16-19)24-20(25(39)35-43(21,40)41)6-7-22(32-24)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,17,19H,4-5,9-12,14-16H2,1-3H3,(H,35,39)	FYFXHOIIPAMYGO-UHFFFAOYSA-N	644607	US11866450, Compound 19::Preparation of 20,20,22-trimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione (Compound 18) and 12,20,20-trimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644607&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400159	490946936							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365125	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N7O4S/c1-26(2)16-18-8-13-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)37(26)17-18)38-14-9-22(35-38)42-15-12-27(10-11-27)28(29,30)31/h3-7,9,14,18H,8,10-13,15-17H2,1-2H3,(H,32,33)(H,36,39)	XAXSKLKSOMDYQS-UHFFFAOYSA-N	644608	US11866450, Compound 20::Preparation of 7,7-dimethyl-11-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.15,8.09,14]tricosa-1(21),9,11,13,18(22),19-hexaene-15,17,17-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644608	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644608&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400015	490946937							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365126	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O4S/c1-26(2)15-18-5-4-13-32-20-6-3-7-23(33-20)43(40,41)36-25(39)19-8-9-21(34-24(19)37(26)16-18)38-14-10-22(35-38)42-17-27(11-12-27)28(29,30)31/h3,6-10,14,18H,4-5,11-13,15-17H2,1-2H3,(H,32,33)(H,36,39)	DVFIQJYZFUHWRT-UHFFFAOYSA-N	644609	US11866450, Compound 22::US11866450, Compound 21	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644609&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400248	490946938							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365127	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O4S/c1-26(2)15-18-5-4-13-32-20-6-3-7-23(33-20)43(40,41)36-25(39)19-8-9-21(34-24(19)37(26)16-18)38-14-10-22(35-38)42-17-27(11-12-27)28(29,30)31/h3,6-10,14,18H,4-5,11-13,15-17H2,1-2H3,(H,32,33)(H,36,39)	DVFIQJYZFUHWRT-UHFFFAOYSA-N	644609	US11866450, Compound 22::US11866450, Compound 21	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644609&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400248	490946938							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365128	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cc(NCCC2)ccn1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-4-3-12-33-20-7-13-34-24(16-20)44(41,42)37-26(40)21-5-6-22(35-25(21)38(27)18-19)39-14-8-23(36-39)43-15-11-28(9-10-28)29(30,31)32/h5-8,13-14,16,19,33H,3-4,9-12,15,17-18H2,1-2H3,(H,37,40)	YINCKKNQNSDEIG-UHFFFAOYSA-N	644611	US11866450, Compound 23::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,22-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione (Hydrochloride Salt) 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644611&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400029	490946939							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365129	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H30F3N7O4S/c1-25(2)14-17-15-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)36(25)16-17)37-12-8-21(34-37)41-13-11-26(9-10-26)27(28,29)30/h3-8,12,17H,9-11,13-16H2,1-2H3,(H,31,32)(H,35,38)	CQZHZNFUSSNRAW-UHFFFAOYSA-N	644612	US11866450, Compound 25::US11866450, Compound 24	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644612&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400260	490946940							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365130	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H30F3N7O4S/c1-25(2)14-17-15-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)36(25)16-17)37-12-8-21(34-37)41-13-11-26(9-10-26)27(28,29)30/h3-8,12,17H,9-11,13-16H2,1-2H3,(H,31,32)(H,35,38)	CQZHZNFUSSNRAW-UHFFFAOYSA-N	644612	US11866450, Compound 25::US11866450, Compound 24	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644612&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400260	490946940							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365131	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O4S/c1-26(2)16-18-8-13-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)37(26)17-18)38-14-9-22(35-38)42-15-12-27(10-11-27)28(29,30)31/h3-7,9,14,18H,8,10-13,15-17H2,1-2H3,(H,32,33)(H,36,39)	XAXSKLKSOMDYQS-UHFFFAOYSA-N	644614	US11866450, Compound 27::US11866450, Compound 26	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644614&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400216	490946941							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365132	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O4S/c1-26(2)16-18-8-13-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)37(26)17-18)38-14-9-22(35-38)42-15-12-27(10-11-27)28(29,30)31/h3-7,9,14,18H,8,10-13,15-17H2,1-2H3,(H,32,33)(H,36,39)	XAXSKLKSOMDYQS-UHFFFAOYSA-N	644614	US11866450, Compound 27::US11866450, Compound 26	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644614&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400216	490946941							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365133	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-3-4-15-34-22-7-5-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-14-29(12-13-29)30(31,32)33/h5,7-11,16,20H,3-4,6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	WQOZGTOMLNOVOC-UHFFFAOYSA-N	644616	US11866450, Compound 28::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.111,14.05,10]pentacosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644616&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399728	490946942							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365134	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-3-4-15-34-22-7-5-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-14-29(12-13-29)30(31,32)33/h5,7-11,16,20H,3-4,6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	WQOZGTOMLNOVOC-UHFFFAOYSA-N	644617	US11866450, Compound 30::US11866450, Compound 29	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644617&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400133	490946943							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365135	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-3-4-15-34-22-7-5-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-14-29(12-13-29)30(31,32)33/h5,7-11,16,20H,3-4,6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	WQOZGTOMLNOVOC-UHFFFAOYSA-N	644617	US11866450, Compound 30::US11866450, Compound 29	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644617&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400133	490946943							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365136	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(N2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C26H28F3N7O4S/c1-24(2)14-16-15-35(24)22-17(23(37)34-41(38,39)21-5-3-4-18(30-16)31-21)6-7-19(32-22)36-12-8-20(33-36)40-13-11-25(9-10-25)26(27,28)29/h3-8,12,16H,9-11,13-15H2,1-2H3,(H,30,31)(H,34,37)	BLGRVHHGYZPHNT-UHFFFAOYSA-N	644619	US11866450, Compound 31::Preparation of 5,5-dimethyl-9-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-15&#955;6-thia-2,6,8,14,20-pentaazatetracyclo[14.3.1.13,6.07,12]henicosa-1(20),7,9,11,16,18-hexaene-13,15,15-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644619&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400102	490946944							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365137	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C27H32F3N7O4S/c1-25(2)16-18-4-3-12-35-13-8-22(33-35)42(39,40)34-24(38)19-5-6-20(31-23(19)36(25)17-18)37-14-7-21(32-37)41-15-11-26(9-10-26)27(28,29)30/h5-8,13-14,18H,3-4,9-12,15-17H2,1-2H3,(H,34,38)	XORJFGSBAKTJDE-UHFFFAOYSA-N	644620	US11866450, Compound 32::Preparation of 20,20-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2(7),3,5,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644620&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399708	490946945							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365138	CC1(C)CC[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)12-10-19-5-4-16-33-21-6-3-7-24(34-21)44(41,42)37-26(40)20-8-9-22(35-25(20)39(19)27)38-17-11-23(36-38)43-18-15-28(13-14-28)29(30,31)32/h3,6-9,11,17,19H,4-5,10,12-16,18H2,1-2H3,(H,33,34)(H,37,40)	MGFSKIVOBYFKPF-UHFFFAOYSA-N	644621	US11866450, Compound 33	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644621&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400051	490946946							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365139	CC1(C)CC[C@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)12-10-19-5-4-16-33-21-6-3-7-24(34-21)44(41,42)37-26(40)20-8-9-22(35-25(20)39(19)27)38-17-11-23(36-38)43-18-15-28(13-14-28)29(30,31)32/h3,6-9,11,17,19H,4-5,10,12-16,18H2,1-2H3,(H,33,34)(H,37,40)	MGFSKIVOBYFKPF-UHFFFAOYSA-N	644622	US11866450, Compound 34::Preparation of (15S)-12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaaza tetracyclo[18.3.1.05,10.011,15]tetracosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione (Compound 33) and (15R)-12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644622&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400052	490946947							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365140	CC1CCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2	InChI=1S/C30H36F3N7O4S/c1-19-7-8-20-17-28(2,3)39(18-20)26-21(27(41)38-45(42,43)25-6-4-5-22(34-19)35-25)9-10-23(36-26)40-15-11-24(37-40)44-16-14-29(12-13-29)30(31,32)33/h4-6,9-11,15,19-20H,7-8,12-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	OTVLYYYADBXMPK-UHFFFAOYSA-N	644623	US11866450, Compound 36::US11866450, Compound 35	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644623&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399777	490946948							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365141	CC1CCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2	InChI=1S/C30H36F3N7O4S/c1-19-7-8-20-17-28(2,3)39(18-20)26-21(27(41)38-45(42,43)25-6-4-5-22(34-19)35-25)9-10-23(36-26)40-15-11-24(37-40)44-16-14-29(12-13-29)30(31,32)33/h4-6,9-11,15,19-20H,7-8,12-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	OTVLYYYADBXMPK-UHFFFAOYSA-N	644623	US11866450, Compound 36::US11866450, Compound 35	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644623&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399777	490946948							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365142	CC1(C)CCC2CCCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H36F3N7O4S/c1-28(2)13-11-20-6-3-4-17-34-22-7-5-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)40(20)28)39-18-12-24(37-39)44-19-16-29(14-15-29)30(31,32)33/h5,7-10,12,18,20H,3-4,6,11,13-17,19H2,1-2H3,(H,34,35)(H,38,41)	DFXLEQZYYWMFCJ-UHFFFAOYSA-N	644625	US11866450, Compound 37::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,20,25-pentaazatetracyclo[19.3.1.05,10.011,15]pentacosa-1(24),5,7,9,21(25),22-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644625	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644625&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399709	490946949							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365143	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(O)n1	InChI=1S/C23H27N7O4S/c1-23(2)13-15-5-4-11-24-17-6-3-7-20(25-17)35(33,34)28-22(32)16-8-9-18(26-21(16)29(23)14-15)30-12-10-19(31)27-30/h3,6-10,12,15H,4-5,11,13-14H2,1-2H3,(H,24,25)(H,27,31)(H,28,32)	PSJSVAFPDPKMGG-UHFFFAOYSA-N	644626	US11866450, Compound 38::Preparation of 8-(3-hydroxy-1H-pyrazol-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (Hydrochloride Salt) 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644626&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400024	490946950							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365144	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H34F3N7O4S/c1-26(2)17-19-5-3-4-13-36-14-9-23(34-36)43(40,41)35-25(39)20-6-7-21(32-24(20)37(26)18-19)38-15-8-22(33-38)42-16-12-27(10-11-27)28(29,30)31/h6-9,14-15,19H,3-5,10-13,16-18H2,1-2H3,(H,35,39)	OREJZOUOAATUOT-UHFFFAOYSA-N	644627	US11866450, Compound 39::Preparation of 21,21-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,23-pentaazatetracyclo[17.2.1.111,14.02,7]tricosa-2,4,6,11(23),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644627&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400023	490946951							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365145	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(OCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H33F3N6O5S/c1-27(2)17-19-5-4-15-42-22-6-3-7-24(34-22)44(40,41)36-26(39)20-8-9-21(33-25(20)37(27)18-19)38-14-10-23(35-38)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,14,19H,4-5,11-13,15-18H2,1-2H3,(H,36,39)	OKVVRVXWPCEMAT-UHFFFAOYSA-N	644628	US11866450, Compound 40	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644628&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399782	490946952							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365146	CC1(C)CCC2CNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C27H30F3N7O4S/c1-25(2)10-8-17-16-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)37(17)25)36-14-9-21(34-36)41-15-13-26(11-12-26)27(28,29)30/h3-7,9,14,17H,8,10-13,15-16H2,1-2H3,(H,31,32)(H,35,38)	AIQAEROFGSMFMX-UHFFFAOYSA-N	644629	US11866450, Compound 41::Preparation of 7,7-dimethyl-11-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.04,8.09,14]docosa-1(22),9,11,13,18,20-hexaene-15,17,17-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644629&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400071	490946953							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365147	CC1(C)C(COc2ccn(n2)-c2ccc3c(n2)N2CC(CC2(C)C)CCCNc2cccc(n2)S(=O)(=O)NC3=O)C1(C)C	InChI=1S/C31H41N7O4S/c1-29(2)17-20-9-8-15-32-23-10-7-11-26(33-23)43(40,41)36-28(39)21-12-13-24(34-27(21)37(29)18-20)38-16-14-25(35-38)42-19-22-30(3,4)31(22,5)6/h7,10-14,16,20,22H,8-9,15,17-19H2,1-6H3,(H,32,33)(H,36,39)	XZRRIQMGMXBZST-UHFFFAOYSA-N	644630	US11866450, Compound 42::Preparation of 12,12-dimethyl-8-{3-[(2,2,3,3-tetramethylcyclopropyl) methoxy]-1H-pyrazol-1-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644630	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644630&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399732	490946954							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365148	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1	InChI=1S/C32H41N7O4S/c1-32(2)19-21-5-4-16-33-26-6-3-7-29(34-26)44(41,42)37-31(40)25-12-13-27(35-30(25)38(32)20-21)39-17-14-28(36-39)43-18-15-24(22-8-9-22)23-10-11-23/h3,6-7,12-14,17,21-24H,4-5,8-11,15-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	KFHWALZGMQAFTD-UHFFFAOYSA-N	644631	US11866450, Compound 43::Preparation of 8-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644631&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399826	490946955							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365149	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H34F3N7O4S/c1-26(2)17-19-5-3-4-13-36-14-9-23(34-36)43(40,41)35-25(39)20-6-7-21(32-24(20)37(26)18-19)38-15-8-22(33-38)42-16-12-27(10-11-27)28(29,30)31/h6-9,14-15,19H,3-5,10-13,16-18H2,1-2H3,(H,35,39)	OREJZOUOAATUOT-UHFFFAOYSA-N	644632	US11866450, Compound 45::US11866450, Compound 44	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644632&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400256	490946956							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365150	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H34F3N7O4S/c1-26(2)17-19-5-3-4-13-36-14-9-23(34-36)43(40,41)35-25(39)20-6-7-21(32-24(20)37(26)18-19)38-15-8-22(33-38)42-16-12-27(10-11-27)28(29,30)31/h6-9,14-15,19H,3-5,10-13,16-18H2,1-2H3,(H,35,39)	OREJZOUOAATUOT-UHFFFAOYSA-N	644632	US11866450, Compound 45::US11866450, Compound 44	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644632&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400256	490946956							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365151	CC1(C)CC[C@H]2CCCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)13-11-20-6-3-4-17-34-22-7-5-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)40(20)28)39-18-12-24(37-39)44-19-16-29(14-15-29)30(31,32)33/h5,7-10,12,18,20H,3-4,6,11,13-17,19H2,1-2H3,(H,34,35)(H,38,41)	DFXLEQZYYWMFCJ-UHFFFAOYSA-N	644634	US11866450, Compound 47::US11866450, Compound 46	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644634&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400138	490946957							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365152	CC1(C)CC[C@H]2CCCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)13-11-20-6-3-4-17-34-22-7-5-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)40(20)28)39-18-12-24(37-39)44-19-16-29(14-15-29)30(31,32)33/h5,7-10,12,18,20H,3-4,6,11,13-17,19H2,1-2H3,(H,34,35)(H,38,41)	DFXLEQZYYWMFCJ-UHFFFAOYSA-N	644634	US11866450, Compound 47::US11866450, Compound 46	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644634&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400138	490946957							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365153	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(OCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H33F3N6O5S/c1-27(2)17-19-5-4-15-42-22-6-3-7-24(34-22)44(40,41)36-26(39)20-8-9-21(33-25(20)37(27)18-19)38-14-10-23(35-38)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,14,19H,4-5,11-13,15-18H2,1-2H3,(H,36,39)	OKVVRVXWPCEMAT-UHFFFAOYSA-N	644636	US11866450, Compound 49::US11866450, Compound 48	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644636	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644636&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400243	490946958							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365154	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(OCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H33F3N6O5S/c1-27(2)17-19-5-4-15-42-22-6-3-7-24(34-22)44(40,41)36-26(39)20-8-9-21(33-25(20)37(27)18-19)38-14-10-23(35-38)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,14,19H,4-5,11-13,15-18H2,1-2H3,(H,36,39)	OKVVRVXWPCEMAT-UHFFFAOYSA-N	644636	US11866450, Compound 49::US11866450, Compound 48	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644636	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644636&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400243	490946958							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365155	CC1(C)CC[C@H]2CNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H30F3N7O4S/c1-25(2)10-8-17-16-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)37(17)25)36-14-9-21(34-36)41-15-13-26(11-12-26)27(28,29)30/h3-7,9,14,17H,8,10-13,15-16H2,1-2H3,(H,31,32)(H,35,38)	AIQAEROFGSMFMX-UHFFFAOYSA-N	644638	US11866450, Compound 51::US11866450, Compound 50	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644638	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644638&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400099	490946959							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365156	CC1(C)CC[C@H]2CNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H30F3N7O4S/c1-25(2)10-8-17-16-31-19-4-3-5-22(32-19)42(39,40)35-24(38)18-6-7-20(33-23(18)37(17)25)36-14-9-21(34-36)41-15-13-26(11-12-26)27(28,29)30/h3-7,9,14,17H,8,10-13,15-16H2,1-2H3,(H,31,32)(H,35,38)	AIQAEROFGSMFMX-UHFFFAOYSA-N	644638	US11866450, Compound 51::US11866450, Compound 50	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644638	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644638&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400099	490946959							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365157	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(CCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C31H36F3N5O4S/c1-29(2)19-22-6-4-3-5-21-7-9-23(10-8-21)44(41,42)37-28(40)24-11-12-25(35-27(24)38(29)20-22)39-17-13-26(36-39)43-18-16-30(14-15-30)31(32,33)34/h7-13,17,22H,3-6,14-16,18-20H2,1-2H3,(H,37,40)	FQIHQVWBOYNLPB-UHFFFAOYSA-N	644640	US11866450, Compound 52	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644640	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644640&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399783	490946960							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365158	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(CCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C31H36F3N5O4S/c1-29(2)19-22-7-4-3-6-21-8-5-9-23(18-21)44(41,42)37-28(40)24-10-11-25(35-27(24)38(29)20-22)39-16-12-26(36-39)43-17-15-30(13-14-30)31(32,33)34/h5,8-12,16,18,22H,3-4,6-7,13-15,17,19-20H2,1-2H3,(H,37,40)	PDGOROHHHJRGHT-UHFFFAOYSA-N	644641	US11866450, Compound 53::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11-triazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644641	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644641&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399741	490946961							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365159	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(CCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H36F3N5O4S/c1-29(2)19-22-6-4-3-5-21-7-9-23(10-8-21)44(41,42)37-28(40)24-11-12-25(35-27(24)38(29)20-22)39-17-13-26(36-39)43-18-16-30(14-15-30)31(32,33)34/h7-13,17,22H,3-6,14-16,18-20H2,1-2H3,(H,37,40)	FQIHQVWBOYNLPB-UHFFFAOYSA-N	644642	US11866450, Compound 55::US11866450, Compound 54	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644642	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644642&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400148	490946962							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365160	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(CCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H36F3N5O4S/c1-29(2)19-22-6-4-3-5-21-7-9-23(10-8-21)44(41,42)37-28(40)24-11-12-25(35-27(24)38(29)20-22)39-17-13-26(36-39)43-18-16-30(14-15-30)31(32,33)34/h7-13,17,22H,3-6,14-16,18-20H2,1-2H3,(H,37,40)	FQIHQVWBOYNLPB-UHFFFAOYSA-N	644642	US11866450, Compound 55::US11866450, Compound 54	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644642	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644642&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400148	490946962							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365161	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(CCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H36F3N5O4S/c1-29(2)19-22-7-4-3-6-21-8-5-9-23(18-21)44(41,42)37-28(40)24-10-11-25(35-27(24)38(29)20-22)39-16-12-26(36-39)43-17-15-30(13-14-30)31(32,33)34/h5,8-12,16,18,22H,3-4,6-7,13-15,17,19-20H2,1-2H3,(H,37,40)	PDGOROHHHJRGHT-UHFFFAOYSA-N	644644	US11866450, Compound 57::US11866450, Compound 56	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644644	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644644&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400261	490946963							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365162	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(CCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H36F3N5O4S/c1-29(2)19-22-7-4-3-6-21-8-5-9-23(18-21)44(41,42)37-28(40)24-10-11-25(35-27(24)38(29)20-22)39-16-12-26(36-39)43-17-15-30(13-14-30)31(32,33)34/h5,8-12,16,18,22H,3-4,6-7,13-15,17,19-20H2,1-2H3,(H,37,40)	PDGOROHHHJRGHT-UHFFFAOYSA-N	644644	US11866450, Compound 57::US11866450, Compound 56	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644644	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644644&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400261	490946963							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365163	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2 |r|	InChI=1S/C30H36F3N7O4S/c1-19-7-8-20-17-28(2,3)39(18-20)26-21(27(41)38-45(42,43)25-6-4-5-22(34-19)35-25)9-10-23(36-26)40-15-11-24(37-40)44-16-14-29(12-13-29)30(31,32)33/h4-6,9-11,15,19-20H,7-8,12-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	OTVLYYYADBXMPK-UHFFFAOYSA-N	644646	US11866450, Compound 59::US11866450, Compound 60::US11866450, Compound 61::US11866450, Compound 58	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644646	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644646&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400250	490946964							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365164	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2 |r|	InChI=1S/C30H36F3N7O4S/c1-19-7-8-20-17-28(2,3)39(18-20)26-21(27(41)38-45(42,43)25-6-4-5-22(34-19)35-25)9-10-23(36-26)40-15-11-24(37-40)44-16-14-29(12-13-29)30(31,32)33/h4-6,9-11,15,19-20H,7-8,12-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	OTVLYYYADBXMPK-UHFFFAOYSA-N	644646	US11866450, Compound 59::US11866450, Compound 60::US11866450, Compound 61::US11866450, Compound 58	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644646	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644646&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400250	490946964							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365165	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2 |r|	InChI=1S/C30H36F3N7O4S/c1-19-7-8-20-17-28(2,3)39(18-20)26-21(27(41)38-45(42,43)25-6-4-5-22(34-19)35-25)9-10-23(36-26)40-15-11-24(37-40)44-16-14-29(12-13-29)30(31,32)33/h4-6,9-11,15,19-20H,7-8,12-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	OTVLYYYADBXMPK-UHFFFAOYSA-N	644646	US11866450, Compound 59::US11866450, Compound 60::US11866450, Compound 61::US11866450, Compound 58	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644646	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644646&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400250	490946964							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365166	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2 |r|	InChI=1S/C30H36F3N7O4S/c1-19-7-8-20-17-28(2,3)39(18-20)26-21(27(41)38-45(42,43)25-6-4-5-22(34-19)35-25)9-10-23(36-26)40-15-11-24(37-40)44-16-14-29(12-13-29)30(31,32)33/h4-6,9-11,15,19-20H,7-8,12-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	OTVLYYYADBXMPK-UHFFFAOYSA-N	644646	US11866450, Compound 59::US11866450, Compound 60::US11866450, Compound 61::US11866450, Compound 58	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644646	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644646&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400250	490946964							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365167	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N7O4S/c1-27(2)16-19-4-3-13-33-22-7-5-20(17-34-22)44(41,42)37-26(40)21-6-8-23(35-25(21)38(27)18-19)39-14-9-24(36-39)43-15-12-28(10-11-28)29(30,31)32/h5-9,14,17,19H,3-4,10-13,15-16,18H2,1-2H3,(H,33,34)(H,37,40)	DPBXHOVKWOVJRD-UHFFFAOYSA-N	644650	US11866450, Compound 62	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644650	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644650&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399785	490946965							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365168	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H38F3N7O4S/c1-29(2)19-21-7-4-3-5-16-35-23-8-6-9-26(36-23)46(43,44)39-28(42)22-10-11-24(37-27(22)40(29)20-21)41-17-12-25(38-41)45-18-15-30(13-14-30)31(32,33)34/h6,8-12,17,21H,3-5,7,13-16,18-20H2,1-2H3,(H,35,36)(H,39,42)	CAGVNFGYBGEZOP-UHFFFAOYSA-N	644651	US11866450, Compound 64::US11866450, Compound 63	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644651	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644651&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400146	490946966							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365169	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H38F3N7O4S/c1-29(2)19-21-7-4-3-5-16-35-23-8-6-9-26(36-23)46(43,44)39-28(42)22-10-11-24(37-27(22)40(29)20-21)41-17-12-25(38-41)45-18-15-30(13-14-30)31(32,33)34/h6,8-12,17,21H,3-5,7,13-16,18-20H2,1-2H3,(H,35,36)(H,39,42)	CAGVNFGYBGEZOP-UHFFFAOYSA-N	644651	US11866450, Compound 64::US11866450, Compound 63	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644651	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644651&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400146	490946966							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365170	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C32H41N7O4S/c1-32(2)19-21-5-4-16-33-26-6-3-7-29(34-26)44(41,42)37-31(40)25-12-13-27(35-30(25)38(32)20-21)39-17-14-28(36-39)43-18-15-24(22-8-9-22)23-10-11-23/h3,6-7,12-14,17,21-24H,4-5,8-11,15-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	KFHWALZGMQAFTD-UHFFFAOYSA-N	644653	Preparation of (14R)-8-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 65	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644653	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644653&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400142	490946967							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365171	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C32H41N7O4S/c1-32(2)19-21-5-4-16-33-26-6-3-7-29(34-26)44(41,42)37-31(40)25-12-13-27(35-30(25)38(32)20-21)39-17-14-28(36-39)43-18-15-24(22-8-9-22)23-10-11-23/h3,6-7,12-14,17,21-24H,4-5,8-11,15-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	KFHWALZGMQAFTD-UHFFFAOYSA-N	644654	Preparation of (14S)-8-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 66	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644654	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644654&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399788	490946968							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365172	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)17-20-5-3-4-14-34-23-8-6-21(18-35-23)45(42,43)38-27(41)22-7-9-24(36-26(22)39(28)19-20)40-15-10-25(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,18,20H,3-5,11-14,16-17,19H2,1-2H3,(H,34,35)(H,38,41)	MIOTXYNSEOIUPC-UHFFFAOYSA-N	644655	US11866450, Compound 68::US11866450, Compound 67	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644655	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644655&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400161	490946969							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365173	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)17-20-5-3-4-14-34-23-8-6-21(18-35-23)45(42,43)38-27(41)22-7-9-24(36-26(22)39(28)19-20)40-15-10-25(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,18,20H,3-5,11-14,16-17,19H2,1-2H3,(H,34,35)(H,38,41)	MIOTXYNSEOIUPC-UHFFFAOYSA-N	644655	US11866450, Compound 68::US11866450, Compound 67	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644655	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644655&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400161	490946969							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365174	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N7O5S/c1-26(2)16-18-17-37(26)24-19(25(39)36-44(40,41)23-5-3-4-20(33-23)32-12-15-42-18)6-7-21(34-24)38-13-8-22(35-38)43-14-11-27(9-10-27)28(29,30)31/h3-8,13,18H,9-12,14-17H2,1-2H3,(H,32,33)(H,36,39)	VCYUNMZMNQKQHP-UHFFFAOYSA-N	644657	Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-15-oxa-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 69	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644657	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644657&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400048	490946970							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365175	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCC2)n1)-n1cc(OCCC2(CC2)C(F)(F)F)cn1	InChI=1S/C30H36F3N7O4S/c1-28(2)16-20-6-3-4-14-34-23-7-5-8-25(36-23)45(42,43)38-27(41)22-9-10-24(37-26(22)39(28)18-20)40-19-21(17-35-40)44-15-13-29(11-12-29)30(31,32)33/h5,7-10,17,19-20H,3-4,6,11-16,18H2,1-2H3,(H,34,36)(H,38,41)	TUKSIEGHLXLZMD-UHFFFAOYSA-N	644658	US11866450, Compound 70	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644658	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644658&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399803	490946971							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365176	Cc1nn2CCCCC3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3	InChI=1S/C29H36F3N7O4S/c1-19-22-18-37(34-19)13-5-4-6-20-16-27(2,3)38(17-20)25-21(26(40)36-44(22,41)42)7-8-23(33-25)39-14-9-24(35-39)43-15-12-28(10-11-28)29(30,31)32/h7-9,14,18,20H,4-6,10-13,15-17H2,1-3H3,(H,36,40)	BZKAXEXAGRCHMW-UHFFFAOYSA-N	644659	Preparation of 21,21,23-trimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[17.2.1.111,14.02,7]tricosa-2,4,6,11(23),12-pentaene-8,10,10-trione (Compound 76) and 12,21,21-trimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[17.2.1.111,14.02,7]tricosa-2,4,6,11(23),12-pentaene-8,10,10-trione ::US11866450, Compound 71	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644659	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644659&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400046	490946972							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365177	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)16-19-4-3-13-33-22-7-5-20(17-34-22)44(41,42)37-26(40)21-6-8-23(35-25(21)38(27)18-19)39-14-9-24(36-39)43-15-12-28(10-11-28)29(30,31)32/h5-9,14,17,19H,3-4,10-13,15-16,18H2,1-2H3,(H,33,34)(H,37,40)	DPBXHOVKWOVJRD-UHFFFAOYSA-N	644660	US11866450, Compound 73::US11866450, Compound 72	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644660	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644660&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400276	490946973							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365178	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)16-19-4-3-13-33-22-7-5-20(17-34-22)44(41,42)37-26(40)21-6-8-23(35-25(21)38(27)18-19)39-14-9-24(36-39)43-15-12-28(10-11-28)29(30,31)32/h5-9,14,17,19H,3-4,10-13,15-16,18H2,1-2H3,(H,33,34)(H,37,40)	DPBXHOVKWOVJRD-UHFFFAOYSA-N	644660	US11866450, Compound 73::US11866450, Compound 72	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644660	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644660&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400276	490946973							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365179	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O5S/c1-26(2)16-18-17-37(26)24-19(25(39)36-44(40,41)23-5-3-4-20(33-23)32-12-15-42-18)6-7-21(34-24)38-13-8-22(35-38)43-14-11-27(9-10-27)28(29,30)31/h3-8,13,18H,9-12,14-17H2,1-2H3,(H,32,33)(H,36,39)	VCYUNMZMNQKQHP-UHFFFAOYSA-N	644662	US11866450, Compound 75::US11866450, Compound 74	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644662	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644662&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400128	490946974							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365180	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O5S/c1-26(2)16-18-17-37(26)24-19(25(39)36-44(40,41)23-5-3-4-20(33-23)32-12-15-42-18)6-7-21(34-24)38-13-8-22(35-38)43-14-11-27(9-10-27)28(29,30)31/h3-8,13,18H,9-12,14-17H2,1-2H3,(H,32,33)(H,36,39)	VCYUNMZMNQKQHP-UHFFFAOYSA-N	644662	US11866450, Compound 75::US11866450, Compound 74	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644662	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644662&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400128	490946974							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365181	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(OCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H34F3N5O5S/c1-28(2)18-20-5-4-15-42-21-6-3-7-22(17-21)44(40,41)36-27(39)23-8-9-24(34-26(23)37(28)19-20)38-14-10-25(35-38)43-16-13-29(11-12-29)30(31,32)33/h3,6-10,14,17,20H,4-5,11-13,15-16,18-19H2,1-2H3,(H,36,39)	IDXZJCSZDOGCQX-UHFFFAOYSA-N	644664	Preparation of (14S)-12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-18-oxa-2&#955;6-thia-3,9,11-triazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione ::US11866450, Compound 77	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644664	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644664&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399849	490946975							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365182	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(CCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H35F3N6O4S/c1-28(2)18-20-6-3-4-7-21-8-5-9-25(34-21)44(41,42)37-27(40)22-10-11-23(35-26(22)38(28)19-20)39-16-12-24(36-39)43-17-15-29(13-14-29)30(31,32)33/h5,8-12,16,20H,3-4,6-7,13-15,17-19H2,1-2H3,(H,37,40)	NCOXSSQMJRPJCP-UHFFFAOYSA-N	644665	Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,23-tetraazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione ::US11866450, Compound 78	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644665	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644665&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399869	490946976							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365183	CC(C)(C)CCC1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H42N6O4S/c1-29(2,3)15-13-21-14-17-35(28(21)38)24-12-11-22-26(33-24)36-19-20(18-30(36,4)5)8-7-16-31-23-9-6-10-25(32-23)41(39,40)34-27(22)37/h6,9-12,20-21H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37)	IYTJLFMMQDYEGS-UHFFFAOYSA-N	644666	Preparation of (14S)-8-[3-(3,3-dimethylbutyl)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione ::US11866450, Compound 79	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644666	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644666&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399800	490946977							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365184	Cc1c2cnn1CCCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C29H36F3N7O4S/c1-19-22-17-33-38(19)13-5-4-6-20-16-27(2,3)37(18-20)25-21(26(40)36-44(22,41)42)7-8-23(34-25)39-14-9-24(35-39)43-15-12-28(10-11-28)29(30,31)32/h7-9,14,17,20H,4-6,10-13,15-16,18H2,1-3H3,(H,36,40)	NQPNDRUAILMRFP-UHFFFAOYSA-N	644667	US11866450, Compound 81::US11866450, Compound 80	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644667	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644667&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400154	490946978							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365185	Cc1c2cnn1CCCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C29H36F3N7O4S/c1-19-22-17-33-38(19)13-5-4-6-20-16-27(2,3)37(18-20)25-21(26(40)36-44(22,41)42)7-8-23(34-25)39-14-9-24(35-39)43-15-12-28(10-11-28)29(30,31)32/h7-9,14,17,20H,4-6,10-13,15-16,18H2,1-3H3,(H,36,40)	NQPNDRUAILMRFP-UHFFFAOYSA-N	644667	US11866450, Compound 81::US11866450, Compound 80	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644667	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644667&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400154	490946978							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365186	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCC2)n1)-n1cc(OCCC2(CC2)C(F)(F)F)cn1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)16-20-6-3-4-14-34-23-7-5-8-25(36-23)45(42,43)38-27(41)22-9-10-24(37-26(22)39(28)18-20)40-19-21(17-35-40)44-15-13-29(11-12-29)30(31,32)33/h5,7-10,17,19-20H,3-4,6,11-16,18H2,1-2H3,(H,34,36)(H,38,41)	TUKSIEGHLXLZMD-UHFFFAOYSA-N	644669	US11866450, Compound 83::US11866450, Compound 82	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644669	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644669&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400171	490946979							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365187	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCCC2)n1)-n1cc(OCCC2(CC2)C(F)(F)F)cn1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)16-20-6-3-4-14-34-23-7-5-8-25(36-23)45(42,43)38-27(41)22-9-10-24(37-26(22)39(28)18-20)40-19-21(17-35-40)44-15-13-29(11-12-29)30(31,32)33/h5,7-10,17,19-20H,3-4,6,11-16,18H2,1-2H3,(H,34,36)(H,38,41)	TUKSIEGHLXLZMD-UHFFFAOYSA-N	644669	US11866450, Compound 83::US11866450, Compound 82	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644669	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644669&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400171	490946979							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365188	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H32F3N7O4S/c1-25(2)16-18-4-3-12-35-13-8-22(33-35)42(39,40)34-24(38)19-5-6-20(31-23(19)36(25)17-18)37-14-7-21(32-37)41-15-11-26(9-10-26)27(28,29)30/h5-8,13-14,18H,3-4,9-12,15-17H2,1-2H3,(H,34,38)	XORJFGSBAKTJDE-UHFFFAOYSA-N	644671	US11866450, Compound 84	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644671	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644671&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399759	490946980							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365189	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H32F3N7O4S/c1-25(2)16-18-4-3-12-35-13-8-22(33-35)42(39,40)34-24(38)19-5-6-20(31-23(19)36(25)17-18)37-14-7-21(32-37)41-15-11-26(9-10-26)27(28,29)30/h5-8,13-14,18H,3-4,9-12,15-17H2,1-2H3,(H,34,38)	XORJFGSBAKTJDE-UHFFFAOYSA-N	644672	Preparation of (18R)-20,20-dimethyl-4-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione (Compound 84) and (18S)-20,20-dimethyl-4-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 85	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644672	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644672&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399760	490946981							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365190	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(CCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H35F3N6O4S/c1-28(2)18-20-6-3-4-7-21-8-5-9-25(34-21)44(41,42)37-27(40)22-10-11-23(35-26(22)38(28)19-20)39-16-12-24(36-39)43-17-15-29(13-14-29)30(31,32)33/h5,8-12,16,20H,3-4,6-7,13-15,17-19H2,1-2H3,(H,37,40)	NCOXSSQMJRPJCP-UHFFFAOYSA-N	644673	US11866450, Compound 87::US11866450, Compound 86	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644673	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644673&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400251	490946982							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365191	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(CCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H35F3N6O4S/c1-28(2)18-20-6-3-4-7-21-8-5-9-25(34-21)44(41,42)37-27(40)22-10-11-23(35-26(22)38(28)19-20)39-16-12-24(36-39)43-17-15-29(13-14-29)30(31,32)33/h5,8-12,16,20H,3-4,6-7,13-15,17-19H2,1-2H3,(H,37,40)	NCOXSSQMJRPJCP-UHFFFAOYSA-N	644673	US11866450, Compound 87::US11866450, Compound 86	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644673	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644673&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400251	490946982							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365192	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H34F3N5O5S/c1-28(2)18-20-4-3-16-42-21-5-7-22(8-6-21)44(40,41)36-27(39)23-9-10-24(34-26(23)37(28)19-20)38-15-11-25(35-38)43-17-14-29(12-13-29)30(31,32)33/h5-11,15,20H,3-4,12-14,16-19H2,1-2H3,(H,36,39)	OHTFKMBPNPYNIP-UHFFFAOYSA-N	644675	US11866450, Compound 88	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644675	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644675&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399764	490946983							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365193	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C31H36F3N5O5S/c1-29(2)19-21-5-3-4-17-43-22-6-8-23(9-7-22)45(41,42)37-28(40)24-10-11-25(35-27(24)38(29)20-21)39-16-12-26(36-39)44-18-15-30(13-14-30)31(32,33)34/h6-12,16,21H,3-5,13-15,17-20H2,1-2H3,(H,37,40)	OFIDXESBTAJPIZ-UHFFFAOYSA-N	644676	US11866450, Compound 89	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644676	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644676&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399761	490946984							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365194	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H33F3N6O5S/c1-27(2)16-19-4-3-14-42-23-8-5-20(17-33-23)44(40,41)36-26(39)21-6-7-22(34-25(21)37(27)18-19)38-13-9-24(35-38)43-15-12-28(10-11-28)29(30,31)32/h5-9,13,17,19H,3-4,10-12,14-16,18H2,1-2H3,(H,36,39)	OAGPVUMKLLOYIR-UHFFFAOYSA-N	644677	Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-18-oxa-2&#955;6-thia-3,9,11,20-tetraazatetracyclo[17.2.2.111,14.05,10]tetracosa-1(21),5(10),6,8,19,22-hexaene-2,2,4-trione ::US11866450, Compound 90	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644677	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644677&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400211	490946985							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365195	Cc1nn2CCCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C29H36F3N7O4S/c1-19-22-18-37(34-19)13-5-4-6-20-16-27(2,3)38(17-20)25-21(26(40)36-44(22,41)42)7-8-23(33-25)39-14-9-24(35-39)43-15-12-28(10-11-28)29(30,31)32/h7-9,14,18,20H,4-6,10-13,15-17H2,1-3H3,(H,36,40)	BZKAXEXAGRCHMW-UHFFFAOYSA-N	644678	US11866450, Compound 92::US11866450, Compound 91	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644678	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644678&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400129	490946986							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365196	Cc1nn2CCCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C29H36F3N7O4S/c1-19-22-18-37(34-19)13-5-4-6-20-16-27(2,3)38(17-20)25-21(26(40)36-44(22,41)42)7-8-23(33-25)39-14-9-24(35-39)43-15-12-28(10-11-28)29(30,31)32/h7-9,14,18,20H,4-6,10-13,15-17H2,1-3H3,(H,36,40)	BZKAXEXAGRCHMW-UHFFFAOYSA-N	644678	US11866450, Compound 92::US11866450, Compound 91	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644678	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644678&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400129	490946986							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365197	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccnc(NCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-4-3-12-33-22-16-20(7-13-34-22)44(41,42)37-26(40)21-5-6-23(35-25(21)38(27)18-19)39-14-8-24(36-39)43-15-11-28(9-10-28)29(30,31)32/h5-8,13-14,16,19H,3-4,9-12,15,17-18H2,1-2H3,(H,33,34)(H,37,40)	XGHCEQHJTJWJOV-UHFFFAOYSA-N	644680	Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,20-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 93	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644680	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644680&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400075	490946987							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365198	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H35F3N6O5S/c1-28(2)17-20-5-3-4-15-43-24-9-6-21(18-34-24)45(41,42)37-27(40)22-7-8-23(35-26(22)38(28)19-20)39-14-10-25(36-39)44-16-13-29(11-12-29)30(31,32)33/h6-10,14,18,20H,3-5,11-13,15-17,19H2,1-2H3,(H,37,40)	BFUZYZHERRWZPD-UHFFFAOYSA-N	644681	Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-19-oxa-2&#955;6-thia-3,9,11,21-tetraazatetracyclo[18.2.2.111,14.05,10]pentacosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione ::US11866450, Compound 94	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644681	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644681&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400058	490946988							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365199	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H36F3N5O5S/c1-29(2)19-21-5-3-4-17-43-22-6-8-23(9-7-22)45(41,42)37-28(40)24-10-11-25(35-27(24)38(29)20-21)39-16-12-26(36-39)44-18-15-30(13-14-30)31(32,33)34/h6-12,16,21H,3-5,13-15,17-20H2,1-2H3,(H,37,40)	OFIDXESBTAJPIZ-UHFFFAOYSA-N	644682	US11866450, Compound 96::US11866450, Compound 95	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644682	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644682&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400252	490946989							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365200	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H36F3N5O5S/c1-29(2)19-21-5-3-4-17-43-22-6-8-23(9-7-22)45(41,42)37-28(40)24-10-11-25(35-27(24)38(29)20-21)39-16-12-26(36-39)44-18-15-30(13-14-30)31(32,33)34/h6-12,16,21H,3-5,13-15,17-20H2,1-2H3,(H,37,40)	OFIDXESBTAJPIZ-UHFFFAOYSA-N	644682	US11866450, Compound 96::US11866450, Compound 95	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644682	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644682&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400252	490946989							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365201	CC1CN(C(=O)C1CCC(C)(C)C)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C31H44N6O4S/c1-20-18-36(29(39)22(20)14-15-30(2,3)4)25-13-12-23-27(34-25)37-19-21(17-31(37,5)6)9-8-16-32-24-10-7-11-26(33-24)42(40,41)35-28(23)38/h7,10-13,20-22H,8-9,14-19H2,1-6H3,(H,32,33)(H,35,38)	XPELXTPSDHTJEC-UHFFFAOYSA-N	644684	Preparation of (14S)-8-[3-(3,3-dimethylbutyl)-4-methyl-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (Hydrochloride Salt) ::US11866450, Compound 97	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644684	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644684&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399710	490946990							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365202	CC(C)(C)CCC1C(=O)N(CC1(C)C)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C32H46N6O4S/c1-30(2,3)16-15-23-29(40)37(20-31(23,4)5)25-14-13-22-27(35-25)38-19-21(18-32(38,6)7)10-9-17-33-24-11-8-12-26(34-24)43(41,42)36-28(22)39/h8,11-14,21,23H,9-10,15-20H2,1-7H3,(H,33,34)(H,36,39)	LKRVUQCHYYIAFF-UHFFFAOYSA-N	644685	Preparation of (14S)-8-[3-(3,3-dimethylbutyl)-4,4-dimethyl-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (hydrochloric acid salt) ::US11866450, Compound 98	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644685	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644685&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399923	490946991							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365203	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H34F3N5O5S/c1-28(2)18-20-4-3-16-42-21-5-7-22(8-6-21)44(40,41)36-27(39)23-9-10-24(34-26(23)37(28)19-20)38-15-11-25(35-38)43-17-14-29(12-13-29)30(31,32)33/h5-11,15,20H,3-4,12-14,16-19H2,1-2H3,(H,36,39)	OHTFKMBPNPYNIP-UHFFFAOYSA-N	644686	US11866450, Compound 100::US11866450, Compound 99	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644686	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644686&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400269	490946992							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365204	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCC2)cc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H34F3N5O5S/c1-28(2)18-20-4-3-16-42-21-5-7-22(8-6-21)44(40,41)36-27(39)23-9-10-24(34-26(23)37(28)19-20)38-15-11-25(35-38)43-17-14-29(12-13-29)30(31,32)33/h5-11,15,20H,3-4,12-14,16-19H2,1-2H3,(H,36,39)	OHTFKMBPNPYNIP-UHFFFAOYSA-N	644686	US11866450, Compound 100::US11866450, Compound 99	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644686	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644686&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400269	490946992							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365205	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCC(CC2(C)CCCCC2)C1=O |r|	InChI=1S/C32H44N6O4S/c1-31(2)19-22-9-8-17-33-25-10-7-11-27(34-25)43(41,42)36-29(39)24-12-13-26(35-28(24)38(31)21-22)37-18-14-23(30(37)40)20-32(3)15-5-4-6-16-32/h7,10-13,22-23H,4-6,8-9,14-21H2,1-3H3,(H,33,34)(H,36,39)	ZPFRNINBRXVHCH-UHFFFAOYSA-N	644688	Preparation of (14S)-12,12-dimethyl-8-{3-[(1-methylcyclohexyl)methyl]-2-oxopyrrolidin-1-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 101	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644688	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644688&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400094	490946993							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365206	CC(C)(C)CCCC1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C31H44N6O4S/c1-30(2,3)16-7-10-22-15-18-36(29(22)39)25-14-13-23-27(34-25)37-20-21(19-31(37,4)5)9-8-17-32-24-11-6-12-26(33-24)42(40,41)35-28(23)38/h6,11-14,21-22H,7-10,15-20H2,1-5H3,(H,32,33)(H,35,38)	STECLYFLSUAHKF-UHFFFAOYSA-N	644689	Preparation of (14S)-8-[3-(4,4-dimethylpentyl)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 102	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644689	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644689&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399763	490946994							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365207	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H35F3N6O5S/c1-28(2)17-20-5-3-4-15-43-24-9-6-21(18-34-24)45(41,42)37-27(40)22-7-8-23(35-26(22)38(28)19-20)39-14-10-25(36-39)44-16-13-29(11-12-29)30(31,32)33/h6-10,14,18,20H,3-5,11-13,15-17,19H2,1-2H3,(H,37,40)	BFUZYZHERRWZPD-UHFFFAOYSA-N	644690	US11866450, Compound 104::US11866450, Compound 103	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644690	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644690&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400151	490946995							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365208	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(OCCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H35F3N6O5S/c1-28(2)17-20-5-3-4-15-43-24-9-6-21(18-34-24)45(41,42)37-27(40)22-7-8-23(35-26(22)38(28)19-20)39-14-10-25(36-39)44-16-13-29(11-12-29)30(31,32)33/h6-10,14,18,20H,3-5,11-13,15-17,19H2,1-2H3,(H,37,40)	BFUZYZHERRWZPD-UHFFFAOYSA-N	644690	US11866450, Compound 104::US11866450, Compound 103	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644690	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644690&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400151	490946995							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365209	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC2C3(CC3)C22CC2)n1	InChI=1S/C31H37N7O4S/c1-29(2)17-20-5-4-15-32-23-6-3-7-26(33-23)43(40,41)36-28(39)21-8-9-24(34-27(21)37(29)18-20)38-16-10-25(35-38)42-19-22-30(11-12-30)31(22)13-14-31/h3,6-10,16,20,22H,4-5,11-15,17-19H2,1-2H3,(H,32,33)(H,36,39)	HVMGUZLRRMRSED-UHFFFAOYSA-N	644692	US11866450, Compound 105	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644692	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644692&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400166	490946996							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365210	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C31H37N7O4S/c1-29(2)17-20-5-4-15-32-23-6-3-7-26(33-23)43(40,41)36-28(39)21-8-9-24(34-27(21)37(29)18-20)38-16-10-25(35-38)42-19-22-30(11-12-30)31(22)13-14-31/h3,6-10,16,20,22H,4-5,11-15,17-19H2,1-2H3,(H,32,33)(H,36,39)	HVMGUZLRRMRSED-UHFFFAOYSA-N	644693	US11866450, Compound 107::US11866450, Compound 106	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644693	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644693&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400147	490946997							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365211	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C31H37N7O4S/c1-29(2)17-20-5-4-15-32-23-6-3-7-26(33-23)43(40,41)36-28(39)21-8-9-24(34-27(21)37(29)18-20)38-16-10-25(35-38)42-19-22-30(11-12-30)31(22)13-14-31/h3,6-10,16,20,22H,4-5,11-15,17-19H2,1-2H3,(H,32,33)(H,36,39)	HVMGUZLRRMRSED-UHFFFAOYSA-N	644693	US11866450, Compound 107::US11866450, Compound 106	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644693	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644693&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400147	490946997							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365212	CC1(C)CCC2CCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N7O4S/c1-26(2)11-8-18-9-15-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)38(18)26)37-16-10-22(35-37)42-17-14-27(12-13-27)28(29,30)31/h3-7,10,16,18H,8-9,11-15,17H2,1-2H3,(H,32,33)(H,36,39)	WILSEBWYHWMGDI-UHFFFAOYSA-N	644695	US11866450, Compound 108	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644695	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644695&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400031	490946998							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365213	Cc1ccc2nc1OCCC[C@@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C30H35F3N6O5S/c1-19-6-9-24-35-27(19)44-15-4-5-20-17-28(2,3)38(18-20)25-21(26(40)37-45(24,41)42)7-8-22(34-25)39-14-10-23(36-39)43-16-13-29(11-12-29)30(31,32)33/h6-10,14,20H,4-5,11-13,15-18H2,1-3H3,(H,37,40)	LJMCISSDNWVSKD-UHFFFAOYSA-N	644696	Preparation of (14S)-12,12,20-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-18-oxa-2&#955;6-thia-3,9,11,23-tetraazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione ::US11866450, Compound 109	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644696	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644696&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400090	490946999							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365214	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cnn(CCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C27H32F3N7O4S/c1-25(2)14-18-4-3-11-35-17-19(15-31-35)42(39,40)34-24(38)20-5-6-21(32-23(20)36(25)16-18)37-12-7-22(33-37)41-13-10-26(8-9-26)27(28,29)30/h5-7,12,15,17-18H,3-4,8-11,13-14,16H2,1-2H3,(H,34,38)	FYFHSAJGKSILLO-UHFFFAOYSA-N	644697	Preparation of 20,20-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 110	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644697	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644697&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400047	490947000							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365215	Cc1c2cnn1CCC[C@@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C28H34F3N7O4S/c1-18-21-16-32-37(18)12-4-5-19-15-26(2,3)36(17-19)24-20(25(39)35-43(21,40)41)6-7-22(33-24)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,19H,4-5,9-12,14-15,17H2,1-3H3,(H,35,39)	QRPXQWNLWOTVOE-UHFFFAOYSA-N	644698	US11866450, Compound 113::US11866450, Compound 111	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644698	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644698&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400093	490947001							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365216	Cc1nn2CCC[C@@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C28H34F3N7O4S/c1-18-21-17-36(33-18)12-4-5-19-15-26(2,3)37(16-19)24-20(25(39)35-43(21,40)41)6-7-22(32-24)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,17,19H,4-5,9-12,14-16H2,1-3H3,(H,35,39)	FYFXHOIIPAMYGO-UHFFFAOYSA-N	644699	US11866450, Compound 112	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644699	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644699&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400165	490947002							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365217	Cc1c2cnn1CCC[C@@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C28H34F3N7O4S/c1-18-21-16-32-37(18)12-4-5-19-15-26(2,3)36(17-19)24-20(25(39)35-43(21,40)41)6-7-22(33-24)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,19H,4-5,9-12,14-15,17H2,1-3H3,(H,35,39)	QRPXQWNLWOTVOE-UHFFFAOYSA-N	644698	US11866450, Compound 113::US11866450, Compound 111	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644698	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644698&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400093	490947001							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365218	Cc1ccc2nc1NCCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C30H36F3N7O4S/c1-19-6-9-24-36-25(19)34-14-4-5-20-17-28(2,3)39(18-20)26-21(27(41)38-45(24,42)43)7-8-22(35-26)40-15-10-23(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,20H,4-5,11-14,16-18H2,1-3H3,(H,34,36)(H,38,41)	POSXXQABNYAJGJ-UHFFFAOYSA-N	644701	US11866450, Compound 115::US11866450, Compound 114	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644701	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644701&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399817	490947003							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365219	Cc1ccc2nc1NCCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C30H36F3N7O4S/c1-19-6-9-24-36-25(19)34-14-4-5-20-17-28(2,3)39(18-20)26-21(27(41)38-45(24,42)43)7-8-22(35-26)40-15-10-23(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,20H,4-5,11-14,16-18H2,1-3H3,(H,34,36)(H,38,41)	POSXXQABNYAJGJ-UHFFFAOYSA-N	644701	US11866450, Compound 115::US11866450, Compound 114	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644701	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644701&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399817	490947003							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365220	CC1(C)CC[C@H]2CCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O4S/c1-26(2)11-8-18-9-15-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)38(18)26)37-16-10-22(35-37)42-17-14-27(12-13-27)28(29,30)31/h3-7,10,16,18H,8-9,11-15,17H2,1-2H3,(H,32,33)(H,36,39)	WILSEBWYHWMGDI-UHFFFAOYSA-N	644703	US11866450, Compound 117::US11866450, Compound 116	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644703	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644703&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400123	490947004							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365221	CC1(C)CC[C@H]2CCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H32F3N7O4S/c1-26(2)11-8-18-9-15-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)38(18)26)37-16-10-22(35-37)42-17-14-27(12-13-27)28(29,30)31/h3-7,10,16,18H,8-9,11-15,17H2,1-2H3,(H,32,33)(H,36,39)	WILSEBWYHWMGDI-UHFFFAOYSA-N	644703	US11866450, Compound 117::US11866450, Compound 116	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644703	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644703&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400123	490947004							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365222	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cnn(CCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H32F3N7O4S/c1-25(2)14-18-4-3-11-35-17-19(15-31-35)42(39,40)34-24(38)20-5-6-21(32-23(20)36(25)16-18)37-12-7-22(33-37)41-13-10-26(8-9-26)27(28,29)30/h5-7,12,15,17-18H,3-4,8-11,13-14,16H2,1-2H3,(H,34,38)	FYFHSAJGKSILLO-UHFFFAOYSA-N	644705	US11866450, Compound 119::US11866450, Compound 118	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644705	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644705&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400212	490947005							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365223	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cnn(CCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H32F3N7O4S/c1-25(2)14-18-4-3-11-35-17-19(15-31-35)42(39,40)34-24(38)20-5-6-21(32-23(20)36(25)16-18)37-12-7-22(33-37)41-13-10-26(8-9-26)27(28,29)30/h5-7,12,15,17-18H,3-4,8-11,13-14,16H2,1-2H3,(H,34,38)	FYFHSAJGKSILLO-UHFFFAOYSA-N	644705	US11866450, Compound 119::US11866450, Compound 118	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644705	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644705&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400212	490947005							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365224	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCCC2)nc1)-n1ccc(OCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)17-21-5-3-4-15-33-25-8-6-22(18-34-25)44(41,42)37-29(40)23-7-9-26(35-28(23)38(30)19-21)39-16-10-27(36-39)43-20-24-31(11-12-31)32(24)13-14-32/h6-10,16,18,21,24H,3-5,11-15,17,19-20H2,1-2H3,(H,33,34)(H,37,40)	WHUDXUWSOVSJRM-UHFFFAOYSA-N	644707	US11866450, Compound 121::US11866450, Compound 120	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644707	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644707&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400150	490947006							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365225	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCCC2)nc1)-n1ccc(OCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)17-21-5-3-4-15-33-25-8-6-22(18-34-25)44(41,42)37-29(40)23-7-9-26(35-28(23)38(30)19-21)39-16-10-27(36-39)43-20-24-31(11-12-31)32(24)13-14-32/h6-10,16,18,21,24H,3-5,11-15,17,19-20H2,1-2H3,(H,33,34)(H,37,40)	WHUDXUWSOVSJRM-UHFFFAOYSA-N	644707	US11866450, Compound 121::US11866450, Compound 120	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644707	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644707&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400150	490947006							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365226	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cnn(CCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H34F3N7O4S/c1-26(2)15-19-5-3-4-12-36-18-20(16-32-36)43(40,41)35-25(39)21-6-7-22(33-24(21)37(26)17-19)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,18-19H,3-5,9-12,14-15,17H2,1-2H3,(H,35,39)	CRBHWVAKYZMMTH-UHFFFAOYSA-N	644709	US11866450, Compound 122::Preparation of 21,21-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[17.2.1.111,14.02,7]tricosa-2,4,6,11(23),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644709	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644709&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400060	490947007							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365227	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCCC2)cn1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C30H36F3N7O4S/c1-28(2)17-20-5-3-4-14-34-21-6-9-25(35-18-21)45(42,43)38-27(41)22-7-8-23(36-26(22)39(28)19-20)40-15-10-24(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,18,20,34H,3-5,11-14,16-17,19H2,1-2H3,(H,38,41)	FFODSACWXHXDHH-UHFFFAOYSA-N	644710	US11866450, Compound 123::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,22-pentaazatetracyclo[18.2.2.111,14.05,10]pentacosa-1(22),5(10),6,8,20,23-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644710	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644710&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400105	490947008							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365228	CC1(C)CC[C@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C31H37N7O4S/c1-29(2)12-10-20-5-4-17-32-23-6-3-7-26(33-23)43(40,41)36-28(39)21-8-9-24(34-27(21)38(20)29)37-18-11-25(35-37)42-19-22-30(13-14-30)31(22)15-16-31/h3,6-9,11,18,20,22H,4-5,10,12-17,19H2,1-2H3,(H,32,33)(H,36,39)	NSRZILVCAWXREO-UHFFFAOYSA-N	644711	US11866450, Compound 125::US11866450, Compound 124	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644711	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644711&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400181	490947009							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365229	CC1(C)CC[C@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C31H37N7O4S/c1-29(2)12-10-20-5-4-17-32-23-6-3-7-26(33-23)43(40,41)36-28(39)21-8-9-24(34-27(21)38(20)29)37-18-11-25(35-37)42-19-22-30(13-14-30)31(22)15-16-31/h3,6-9,11,18,20,22H,4-5,10,12-17,19H2,1-2H3,(H,32,33)(H,36,39)	NSRZILVCAWXREO-UHFFFAOYSA-N	644711	US11866450, Compound 125::US11866450, Compound 124	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644711	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644711&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400181	490947009							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365230	CC(C)(C)CC[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H42N6O4S/c1-29(2,3)15-13-21-14-17-35(28(21)38)24-12-11-22-26(33-24)36-19-20(18-30(36,4)5)8-7-16-31-23-9-6-10-25(32-23)41(39,40)34-27(22)37/h6,9-12,20-21H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37)	IYTJLFMMQDYEGS-UHFFFAOYSA-N	644713	US11866450, Compound 127::US11866450, Compound 126	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644713	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644713&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400179	490947010							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365231	CC(C)(C)CC[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H42N6O4S/c1-29(2,3)15-13-21-14-17-35(28(21)38)24-12-11-22-26(33-24)36-19-20(18-30(36,4)5)8-7-16-31-23-9-6-10-25(32-23)41(39,40)34-27(22)37/h6,9-12,20-21H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37)	IYTJLFMMQDYEGS-UHFFFAOYSA-N	644713	US11866450, Compound 127::US11866450, Compound 126	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644713	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644713&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400179	490947010							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365232	CC(C)(C)CCN1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C29H41N7O4S/c1-28(2,3)13-15-34-16-17-35(27(34)38)23-12-11-21-25(32-23)36-19-20(18-29(36,4)5)8-7-14-30-22-9-6-10-24(31-22)41(39,40)33-26(21)37/h6,9-12,20H,7-8,13-19H2,1-5H3,(H,30,31)(H,33,37)	YENCSQJKALMWFH-UHFFFAOYSA-N	644715	US11866450, Compound 128::Preparation of (14S)-8-[3-(3,3-dimethylbutyl)-2-oxoimidazolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644715	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644715&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400104	490947011							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365233	Cc1ccc2NCCCC3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3	InChI=1S/C30H36F3N7O4S/c1-19-6-8-22-34-14-4-5-20-17-28(2,3)39(18-20)25-21(26(41)38-45(42,43)27(19)35-22)7-9-23(36-25)40-15-10-24(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,20H,4-5,11-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	GROCSBVDCPOPPL-UHFFFAOYSA-N	644716	US11866450, Compound 129::Preparation of 12,12,22-trimethyl-8-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644716	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644716&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399816	490947012							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365234	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(NCCCC2)nc1)-n1ccc(OCCC(C2CC2)C2CC2)n1	InChI=1S/C33H43N7O4S/c1-33(2)19-22-5-3-4-16-34-28-12-10-25(20-35-28)45(42,43)38-32(41)27-11-13-29(36-31(27)39(33)21-22)40-17-14-30(37-40)44-18-15-26(23-6-7-23)24-8-9-24/h10-14,17,20,22-24,26H,3-9,15-16,18-19,21H2,1-2H3,(H,34,35)(H,38,41)	FRVDQUSGMHCPEM-UHFFFAOYSA-N	644717	US11866450, Compound 130::Preparation of 8-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,19,21-pentaazatetracyclo[18.2.2.111,14.05,10]pentacosa-1(22),5,7,9,20,23-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644717	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644717&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399821	490947013							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365235	CC1(C)CCC2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC(C2CC2)C2CC2)n1	InChI=1S/C32H41N7O4S/c1-32(2)17-14-23-5-4-18-33-26-6-3-7-29(34-26)44(41,42)37-31(40)25-12-13-27(35-30(25)39(23)32)38-19-15-28(36-38)43-20-16-24(21-8-9-21)22-10-11-22/h3,6-7,12-13,15,19,21-24H,4-5,8-11,14,16-18,20H2,1-2H3,(H,33,34)(H,37,40)	YEIFNZNPZCNGMN-UHFFFAOYSA-N	644718	US11866450, Compound 131::Preparation of 8-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(23),5(10),6,8,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644718	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644718&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399804	490947014							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365236	CN1CCCCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3ccc1nc3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2	InChI=1S/C31H38F3N7O4S/c1-29(2)18-21-6-4-5-15-39(3)24-9-7-22(19-35-24)46(43,44)38-28(42)23-8-10-25(36-27(23)40(29)20-21)41-16-11-26(37-41)45-17-14-30(12-13-30)31(32,33)34/h7-11,16,19,21H,4-6,12-15,17-18,20H2,1-3H3,(H,38,42)	VKCHXLDFENQXPP-UHFFFAOYSA-N	644719	US11866450, Compound 132::Preparation of 12,12,19-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,19,21-pentaazatetracyclo[18.2.2.111,14.05,10]pentacosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644719	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644719&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399819	490947015							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365237	CN1CCCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc1n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-5-15-38(3)22-7-4-8-25(34-22)45(42,43)37-27(41)21-9-10-23(35-26(21)39(28)19-20)40-16-11-24(36-40)44-17-14-29(12-13-29)30(31,32)33/h4,7-11,16,20H,5-6,12-15,17-19H2,1-3H3,(H,37,41)	UWQGAXPVQABSFV-UHFFFAOYSA-N	644720	US11866450, Compound 133::Preparation of 12,12,18-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644720	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644720&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399808	490947016							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365238	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cnn(CCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H34F3N7O4S/c1-26(2)15-19-5-3-4-12-36-18-20(16-32-36)43(40,41)35-25(39)21-6-7-22(33-24(21)37(26)17-19)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,18-19H,3-5,9-12,14-15,17H2,1-2H3,(H,35,39)	CRBHWVAKYZMMTH-UHFFFAOYSA-N	644721	US11866450, Compound 135::US11866450, Compound 134	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644721	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644721&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400170	490947017							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365239	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cnn(CCCC2)c1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H34F3N7O4S/c1-26(2)15-19-5-3-4-12-36-18-20(16-32-36)43(40,41)35-25(39)21-6-7-22(33-24(21)37(26)17-19)38-13-8-23(34-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,18-19H,3-5,9-12,14-15,17H2,1-2H3,(H,35,39)	CRBHWVAKYZMMTH-UHFFFAOYSA-N	644721	US11866450, Compound 135::US11866450, Compound 134	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644721	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644721&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400170	490947017							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365240	CC1(C)CC[C@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C32H41N7O4S/c1-32(2)17-14-23-5-4-18-33-26-6-3-7-29(34-26)44(41,42)37-31(40)25-12-13-27(35-30(25)39(23)32)38-19-15-28(36-38)43-20-16-24(21-8-9-21)22-10-11-22/h3,6-7,12-13,15,19,21-24H,4-5,8-11,14,16-18,20H2,1-2H3,(H,33,34)(H,37,40)	YEIFNZNPZCNGMN-UHFFFAOYSA-N	644723	US11866450, Compound 137::US11866450, Compound 136	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644723	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644723&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400186	490947018							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365241	CC1(C)CC[C@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C32H41N7O4S/c1-32(2)17-14-23-5-4-18-33-26-6-3-7-29(34-26)44(41,42)37-31(40)25-12-13-27(35-30(25)39(23)32)38-19-15-28(36-38)43-20-16-24(21-8-9-21)22-10-11-22/h3,6-7,12-13,15,19,21-24H,4-5,8-11,14,16-18,20H2,1-2H3,(H,33,34)(H,37,40)	YEIFNZNPZCNGMN-UHFFFAOYSA-N	644723	US11866450, Compound 137::US11866450, Compound 136	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644723	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644723&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400186	490947018							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365242	CN1CCC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc1n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-5-15-38(3)22-7-4-8-25(34-22)45(42,43)37-27(41)21-9-10-23(35-26(21)39(28)19-20)40-16-11-24(36-40)44-17-14-29(12-13-29)30(31,32)33/h4,7-11,16,20H,5-6,12-15,17-19H2,1-3H3,(H,37,41)	UWQGAXPVQABSFV-UHFFFAOYSA-N	644725	US11866450, Compound 139::US11866450, Compound 138	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644725	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644725&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400182	490947019							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365243	CN1CCC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc1n3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-5-15-38(3)22-7-4-8-25(34-22)45(42,43)37-27(41)21-9-10-23(35-26(21)39(28)19-20)40-16-11-24(36-40)44-17-14-29(12-13-29)30(31,32)33/h4,7-11,16,20H,5-6,12-15,17-19H2,1-3H3,(H,37,41)	UWQGAXPVQABSFV-UHFFFAOYSA-N	644725	US11866450, Compound 139::US11866450, Compound 138	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644725	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644725&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400182	490947019							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365244	CN1CCCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3ccc1nc3)-n1ccc(OCCC3(CC3)C(F)(F)F)n1)C(C)(C)C2	InChI=1S/C30H36F3N7O4S/c1-28(2)17-20-5-4-14-38(3)23-8-6-21(18-34-23)45(42,43)37-27(41)22-7-9-24(35-26(22)39(28)19-20)40-15-10-25(36-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,18,20H,4-5,11-14,16-17,19H2,1-3H3,(H,37,41)	OCXDUHXZYIQNKH-UHFFFAOYSA-N	644727	US11866450, Compound 140::Preparation of 12,12,18-trimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,20-pentaazatetracyclo[17.2.2.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644727	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644727&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400279	490947020							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365245	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1	InChI=1S/C30H39N7O4S/c1-30(2)18-20-4-3-14-35-15-12-27(33-35)42(39,40)34-29(38)24-9-10-25(31-28(24)36(30)19-20)37-16-11-26(32-37)41-17-13-23(21-5-6-21)22-7-8-22/h9-12,15-16,20-23H,3-8,13-14,17-19H2,1-2H3,(H,34,38)	ABSUYJXVRLPGTO-UHFFFAOYSA-N	644728	US11866450, Compound 141::Preparation of 4-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644728	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644728&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399825	490947021							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365246	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(CCCCC2)nc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C31H37F3N6O4S/c1-29(2)18-21-6-4-3-5-7-22-8-9-23(19-35-22)45(42,43)38-28(41)24-10-11-25(36-27(24)39(29)20-21)40-16-12-26(37-40)44-17-15-30(13-14-30)31(32,33)34/h8-12,16,19,21H,3-7,13-15,17-18,20H2,1-2H3,(H,38,41)	NBWRRTMQXKCICN-UHFFFAOYSA-N	644729	US11866450, Compound 142::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,21-tetraazatetracyclo[18.2.2.111,14.05,10]pentacosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644729	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644729&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400064	490947022							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365247	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(CCCCC2)cn1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C31H37F3N6O4S/c1-29(2)18-22-7-5-3-4-6-21-8-11-26(35-19-21)45(42,43)38-28(41)23-9-10-24(36-27(23)39(29)20-22)40-16-12-25(37-40)44-17-15-30(13-14-30)31(32,33)34/h8-12,16,19,22H,3-7,13-15,17-18,20H2,1-2H3,(H,38,41)	WQMBERGMCUDKQA-UHFFFAOYSA-N	644730	US11866450, Compound 143::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,22-tetraazatetracyclo[18.2.2.111,14.05,10]pentacosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644730	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644730&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400056	490947023							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365248	Cc1cc2nn1CCCC1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H34F3N7O4S/c1-18-15-23-34-37(18)12-4-5-19-16-26(2,3)36(17-19)24-20(25(39)35-43(23,40)41)6-7-21(32-24)38-13-8-22(33-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,15,19H,4-5,9-12,14,16-17H2,1-3H3,(H,35,39)	PTURMXOTAXPQDX-UHFFFAOYSA-N	644731	US11866450, Compound 144::Preparation of 13,20,20-trimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,22-pentaaza tetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644731	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644731&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400078	490947024							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365249	CC(C)(C)CCC[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C31H44N6O4S/c1-30(2,3)16-7-10-22-15-18-36(29(22)39)25-14-13-23-27(34-25)37-20-21(19-31(37,4)5)9-8-17-32-24-11-6-12-26(33-24)42(40,41)35-28(23)38/h6,11-14,21-22H,7-10,15-20H2,1-5H3,(H,32,33)(H,35,38)	STECLYFLSUAHKF-UHFFFAOYSA-N	644732	US11866450, Compound 146::US11866450, Compound 145	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644732	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644732&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400176	490947025							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365250	CC(C)(C)CCC[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C31H44N6O4S/c1-30(2,3)16-7-10-22-15-18-36(29(22)39)25-14-13-23-27(34-25)37-20-21(19-31(37,4)5)9-8-17-32-24-11-6-12-26(33-24)42(40,41)35-28(23)38/h6,11-14,21-22H,7-10,15-20H2,1-5H3,(H,32,33)(H,35,38)	STECLYFLSUAHKF-UHFFFAOYSA-N	644732	US11866450, Compound 146::US11866450, Compound 145	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644732	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644732&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400176	490947025							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365251	CC1(C)CCC2CCCOc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H33F3N6O5S/c1-27(2)12-10-19-5-4-17-42-22-6-3-7-24(34-22)44(40,41)36-26(39)20-8-9-21(33-25(20)38(19)27)37-16-11-23(35-37)43-18-15-28(13-14-28)29(30,31)32/h3,6-9,11,16,19H,4-5,10,12-15,17-18H2,1-2H3,(H,36,39)	KYBKPSYTRDNTGD-UHFFFAOYSA-N	644734	US11866450, Compound 147::Preparation of 12,12-dimethyl-8-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-19-oxa-2&#955;6-thia-3,9,11,24-tetraazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(24),5(10),6,8,20,22-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644734	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644734&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400066	490947026							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365252	Cc1ccc2NCCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C30H36F3N7O4S/c1-19-6-8-22-34-14-4-5-20-17-28(2,3)39(18-20)25-21(26(41)38-45(42,43)27(19)35-22)7-9-23(36-25)40-15-10-24(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,20H,4-5,11-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	GROCSBVDCPOPPL-UHFFFAOYSA-N	644735	US11866450, Compound 149::US11866450, Compound 148	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644735	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644735&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400162	490947027							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365253	Cc1ccc2NCCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C30H36F3N7O4S/c1-19-6-8-22-34-14-4-5-20-17-28(2,3)39(18-20)25-21(26(41)38-45(42,43)27(19)35-22)7-9-23(36-25)40-15-10-24(37-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,20H,4-5,11-14,16-18H2,1-3H3,(H,34,35)(H,38,41)	GROCSBVDCPOPPL-UHFFFAOYSA-N	644735	US11866450, Compound 149::US11866450, Compound 148	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644735	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644735&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400162	490947027							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365254	Cc1cc2nn1CCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C28H34F3N7O4S/c1-18-15-23-34-37(18)12-4-5-19-16-26(2,3)36(17-19)24-20(25(39)35-43(23,40)41)6-7-21(32-24)38-13-8-22(33-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,15,19H,4-5,9-12,14,16-17H2,1-3H3,(H,35,39)	PTURMXOTAXPQDX-UHFFFAOYSA-N	644737	US11866450, Compound 151::US11866450, Compound 150	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644737	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644737&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400245	490947028							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365255	Cc1cc2nn1CCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C28H34F3N7O4S/c1-18-15-23-34-37(18)12-4-5-19-16-26(2,3)36(17-19)24-20(25(39)35-43(23,40)41)6-7-21(32-24)38-13-8-22(33-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,15,19H,4-5,9-12,14,16-17H2,1-3H3,(H,35,39)	PTURMXOTAXPQDX-UHFFFAOYSA-N	644737	US11866450, Compound 151::US11866450, Compound 150	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644737	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644737&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400245	490947028							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365256	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccnn1CCO2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C26H30F3N7O5S/c1-24(2)15-17-16-34(24)22-18(23(37)33-42(38,39)21-5-10-30-36(21)12-14-40-17)3-4-19(31-22)35-11-6-20(32-35)41-13-9-25(7-8-25)26(27,28)29/h3-6,10-11,17H,7-9,12-16H2,1-2H3,(H,33,37)	RBHHIPIDTLYWDQ-UHFFFAOYSA-N	644739	US11866450, Compound 152::Preparation of 21,21-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-18-oxa-10&#955;6-thia-1,3,9,14,15-pentaazatetracyclo[17.2.1.02,7.011,15]docosa-2(7),3,5,11,13-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644739	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644739&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400111	490947029							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365257	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C30H39N7O4S/c1-30(2)18-20-4-3-14-35-15-12-27(33-35)42(39,40)34-29(38)24-9-10-25(31-28(24)36(30)19-20)37-16-11-26(32-37)41-17-13-23(21-5-6-21)22-7-8-22/h9-12,15-16,20-23H,3-8,13-14,17-19H2,1-2H3,(H,34,38)	ABSUYJXVRLPGTO-UHFFFAOYSA-N	644740	US11866450, Compound 154::US11866450, Compound 153	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644740	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644740&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400193	490947030							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365258	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C30H39N7O4S/c1-30(2)18-20-4-3-14-35-15-12-27(33-35)42(39,40)34-29(38)24-9-10-25(31-28(24)36(30)19-20)37-16-11-26(32-37)41-17-13-23(21-5-6-21)22-7-8-22/h9-12,15-16,20-23H,3-8,13-14,17-19H2,1-2H3,(H,34,38)	ABSUYJXVRLPGTO-UHFFFAOYSA-N	644740	US11866450, Compound 154::US11866450, Compound 153	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644740	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644740&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400193	490947030							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365259	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H34F3N7O4S/c1-26(2)17-19-5-3-13-36-14-9-23(34-36)43(40,41)35-25(39)20-6-7-21(32-24(20)37(26)18-19)38-15-8-22(33-38)42-16-4-10-27(11-12-27)28(29,30)31/h6-9,14-15,19H,3-5,10-13,16-18H2,1-2H3,(H,35,39)	VWFVMAXDADHXOH-UHFFFAOYSA-N	644742	US11866450, Compound 155	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644742	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644742&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399854	490947031							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365260	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1	InChI=1S/C31H39N7O5S/c1-31(2)18-22-19-37(31)29-24(30(39)36-44(40,41)28-5-3-4-25(33-28)32-14-17-42-22)10-11-26(34-29)38-15-12-27(35-38)43-16-13-23(20-6-7-20)21-8-9-21/h3-5,10-12,15,20-23H,6-9,13-14,16-19H2,1-2H3,(H,32,33)(H,36,39)	PGXXQEAJKFJTGT-UHFFFAOYSA-N	644743	US11866450, Compound 156	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644743	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644743&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399707	490947032							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365261	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N7O5S/c1-27(2)17-19-18-38(27)25-20(26(40)37-45(41,42)24-6-3-5-21(34-24)33-13-16-43-19)7-8-22(35-25)39-14-9-23(36-39)44-15-4-10-28(11-12-28)29(30,31)32/h3,5-9,14,19H,4,10-13,15-18H2,1-2H3,(H,33,34)(H,37,40)	GCCURUUCPNDJIW-UHFFFAOYSA-N	644744	US11866450, Compound 157	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644744	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644744&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399853	490947033							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365262	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCC(OCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C30H37F3N6O5S/c1-28(2)17-19-5-4-14-34-22-6-3-7-24(35-22)45(42,43)37-26(40)20-8-9-23(36-25(20)39(28)18-19)38-15-10-21(27(38)41)44-16-13-29(11-12-29)30(31,32)33/h3,6-9,19,21H,4-5,10-18H2,1-2H3,(H,34,35)(H,37,40)	MFBGGLGENXKEJB-UHFFFAOYSA-N	644745	US11866450, Compound 158::Preparation of (14S)-12,12-dimethyl-8-(2-oxo-3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}pyrrolidin-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644745	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644745&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400067	490947034							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365263	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O5S/c1-27(2)17-19-18-38(27)25-20(26(40)37-45(41,42)24-6-3-5-21(34-24)33-13-16-43-19)7-8-22(35-25)39-14-9-23(36-39)44-15-4-10-28(11-12-28)29(30,31)32/h3,5-9,14,19H,4,10-13,15-18H2,1-2H3,(H,33,34)(H,37,40)	GCCURUUCPNDJIW-UHFFFAOYSA-N	644746	US11866450, Compound 160::US11866450, Compound 159	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644746	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644746&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400265	490947035							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365264	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O5S/c1-27(2)17-19-18-38(27)25-20(26(40)37-45(41,42)24-6-3-5-21(34-24)33-13-16-43-19)7-8-22(35-25)39-14-9-23(36-39)44-15-4-10-28(11-12-28)29(30,31)32/h3,5-9,14,19H,4,10-13,15-18H2,1-2H3,(H,33,34)(H,37,40)	GCCURUUCPNDJIW-UHFFFAOYSA-N	644746	US11866450, Compound 160::US11866450, Compound 159	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644746	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644746&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400265	490947035							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365265	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-4-15-34-22-7-3-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-5-12-29(13-14-29)30(31,32)33/h3,7-11,16,20H,4-6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	GKMTUBDABPEEBO-UHFFFAOYSA-N	644748	US11866450, Compound 270::US11866450, Compound 292::Preparation of (14S)-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl) cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 287::US11866450, Compound 161	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644748&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399822	490947036							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365266	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C31H39N7O5S/c1-31(2)18-22-19-37(31)29-24(30(39)36-44(40,41)28-5-3-4-25(33-28)32-14-17-42-22)10-11-26(34-29)38-15-12-27(35-38)43-16-13-23(20-6-7-20)21-8-9-21/h3-5,10-12,15,20-23H,6-9,13-14,16-19H2,1-2H3,(H,32,33)(H,36,39)	PGXXQEAJKFJTGT-UHFFFAOYSA-N	644749	US11866450, Compound 163::US11866450, Compound 162	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644749	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644749&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400295	490947037							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365267	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C31H39N7O5S/c1-31(2)18-22-19-37(31)29-24(30(39)36-44(40,41)28-5-3-4-25(33-28)32-14-17-42-22)10-11-26(34-29)38-15-12-27(35-38)43-16-13-23(20-6-7-20)21-8-9-21/h3-5,10-12,15,20-23H,6-9,13-14,16-19H2,1-2H3,(H,32,33)(H,36,39)	PGXXQEAJKFJTGT-UHFFFAOYSA-N	644749	US11866450, Compound 163::US11866450, Compound 162	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644749	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644749&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400295	490947037							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365268	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCO2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C26H30F3N7O5S/c1-24(2)15-17-16-35(24)22-18(23(37)33-42(38,39)21-6-10-34(32-21)12-14-40-17)3-4-19(30-22)36-11-5-20(31-36)41-13-9-25(7-8-25)26(27,28)29/h3-6,10-11,17H,7-9,12-16H2,1-2H3,(H,33,37)	OEVMKEKULSFZIY-UHFFFAOYSA-N	644751	US11866450, Compound 164	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644751	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644751&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400141	490947038							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365269	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H34F3N7O4S/c1-26(2)17-19-5-3-13-36-14-9-23(34-36)43(40,41)35-25(39)20-6-7-21(32-24(20)37(26)18-19)38-15-8-22(33-38)42-16-4-10-27(11-12-27)28(29,30)31/h6-9,14-15,19H,3-5,10-13,16-18H2,1-2H3,(H,35,39)	VWFVMAXDADHXOH-UHFFFAOYSA-N	644752	US11866450, Compound 166::US11866450, Compound 165	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644752	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644752&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400187	490947039							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365270	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C28H34F3N7O4S/c1-26(2)17-19-5-3-13-36-14-9-23(34-36)43(40,41)35-25(39)20-6-7-21(32-24(20)37(26)18-19)38-15-8-22(33-38)42-16-4-10-27(11-12-27)28(29,30)31/h6-9,14-15,19H,3-5,10-13,16-18H2,1-2H3,(H,35,39)	VWFVMAXDADHXOH-UHFFFAOYSA-N	644752	US11866450, Compound 166::US11866450, Compound 165	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644752	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644752&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400187	490947039							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365271	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCO2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C26H30F3N7O5S/c1-24(2)15-17-16-35(24)22-18(23(37)33-42(38,39)21-6-10-34(32-21)12-14-40-17)3-4-19(30-22)36-11-5-20(31-36)41-13-9-25(7-8-25)26(27,28)29/h3-6,10-11,17H,7-9,12-16H2,1-2H3,(H,33,37)	OEVMKEKULSFZIY-UHFFFAOYSA-N	644754	US11866450, Compound 302::Preparation of 20,20-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-17-oxa-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2(7),3,5,11(22),12-pentaene-8,10,10-trione::US11866450, Compound 167	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644754	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644754&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400172	490947040							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365272	CC(C)(C)CCN1CCN(C1=O)c1ccc2c(n1)N1CC(CC1(C)C)CCCn1ccc(n1)S(=O)(=O)NC2=O	InChI=1S/C27H39N7O4S/c1-26(2,3)11-14-31-15-16-33(25(31)36)21-9-8-20-23(28-21)34-18-19(17-27(34,4)5)7-6-12-32-13-10-22(29-32)39(37,38)30-24(20)35/h8-10,13,19H,6-7,11-12,14-18H2,1-5H3,(H,30,35)	SGZMSNKHNUWSKG-UHFFFAOYSA-N	644755	Preparation of 4-[3-(3,3-dimethylbutyl)-2-oxoimidazolidin-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 168	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644755&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400073	490947041							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365273	CC(C)(C)CCCN1CCN(C1=O)c1ccc2c(n1)N1CC(CC1(C)C)CCCn1ccc(n1)S(=O)(=O)NC2=O	InChI=1S/C28H41N7O4S/c1-27(2,3)12-7-13-32-16-17-34(26(32)37)22-10-9-21-24(29-22)35-19-20(18-28(35,4)5)8-6-14-33-15-11-23(30-33)40(38,39)31-25(21)36/h9-11,15,20H,6-8,12-14,16-19H2,1-5H3,(H,31,36)	NFDCGOKDBYDGDL-UHFFFAOYSA-N	644756	Preparation of 4-[3-(4,4-dimethylpentyl)-2-oxoimidazolidin-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 169	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644756	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644756&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400200	490947042							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365274	CC(C)(C)CCO[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H42N6O5S/c1-29(2,3)14-17-41-22-13-16-35(28(22)38)24-12-11-21-26(33-24)36-19-20(18-30(36,4)5)8-7-15-31-23-9-6-10-25(32-23)42(39,40)34-27(21)37/h6,9-12,20,22H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37)	IMILJFJHBOKTCU-UHFFFAOYSA-N	644757	US11866450, Compound 171::US11866450, Compound 170	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644757	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644757&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400271	490947043							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365275	CC(C)(C)CCO[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H42N6O5S/c1-29(2,3)14-17-41-22-13-16-35(28(22)38)24-12-11-21-26(33-24)36-19-20(18-30(36,4)5)8-7-15-31-23-9-6-10-25(32-23)42(39,40)34-27(21)37/h6,9-12,20,22H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37)	IMILJFJHBOKTCU-UHFFFAOYSA-N	644757	US11866450, Compound 171::US11866450, Compound 170	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644757	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644757&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400271	490947043							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365276	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C30H37F3N6O5S/c1-28(2)17-19-5-4-14-34-22-6-3-7-24(35-22)45(42,43)37-26(40)20-8-9-23(36-25(20)39(28)18-19)38-15-10-21(27(38)41)44-16-13-29(11-12-29)30(31,32)33/h3,6-9,19,21H,4-5,10-18H2,1-2H3,(H,34,35)(H,37,40)	MFBGGLGENXKEJB-UHFFFAOYSA-N	644759	US11866450, Compound 173::US11866450, Compound 172	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644759	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644759&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400254	490947044							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365277	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C30H37F3N6O5S/c1-28(2)17-19-5-4-14-34-22-6-3-7-24(35-22)45(42,43)37-26(40)20-8-9-23(36-25(20)39(28)18-19)38-15-10-21(27(38)41)44-16-13-29(11-12-29)30(31,32)33/h3,6-9,19,21H,4-5,10-18H2,1-2H3,(H,34,35)(H,37,40)	MFBGGLGENXKEJB-UHFFFAOYSA-N	644759	US11866450, Compound 173::US11866450, Compound 172	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644759	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644759&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400254	490947044							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365278	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](CCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C31H39F3N6O4S/c1-29(2)18-20-6-5-16-35-23-8-3-9-25(36-23)45(43,44)38-27(41)22-10-11-24(37-26(22)40(29)19-20)39-17-12-21(28(39)42)7-4-13-30(14-15-30)31(32,33)34/h3,8-11,20-21H,4-7,12-19H2,1-2H3,(H,35,36)(H,38,41)	OVZWZYXAAKNSLU-UHFFFAOYSA-N	644761	US11866450, Compound 175::US11866450, Compound 174	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644761	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644761&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400183	490947045							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365279	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](CCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C31H39F3N6O4S/c1-29(2)18-20-6-5-16-35-23-8-3-9-25(36-23)45(43,44)38-27(41)22-10-11-24(37-26(22)40(29)19-20)39-17-12-21(28(39)42)7-4-13-30(14-15-30)31(32,33)34/h3,8-11,20-21H,4-7,12-19H2,1-2H3,(H,35,36)(H,38,41)	OVZWZYXAAKNSLU-UHFFFAOYSA-N	644761	US11866450, Compound 175::US11866450, Compound 174	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644761	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644761&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400183	490947045							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365280	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1	InChI=1S/C30H37N7O4S/c1-28(2)18-20-4-3-14-35-15-8-25(33-35)42(39,40)34-27(38)21-5-6-23(31-26(21)36(28)19-20)37-16-7-24(32-37)41-17-9-22-29(10-11-29)30(22)12-13-30/h5-8,15-16,20,22H,3-4,9-14,17-19H2,1-2H3,(H,34,38)	WNQPJIPCJFYVHJ-UHFFFAOYSA-N	644763	Preparation of 4-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 176	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644763	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644763&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400068	490947046							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365281	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](CCC2C3(CC3)C22CC2)C1=O |r|	InChI=1S/C33H42N6O4S/c1-31(2)19-21-5-4-17-34-25-6-3-7-27(35-25)44(42,43)37-29(40)23-9-11-26(36-28(23)39(31)20-21)38-18-12-22(30(38)41)8-10-24-32(13-14-32)33(24)15-16-33/h3,6-7,9,11,21-22,24H,4-5,8,10,12-20H2,1-2H3,(H,34,35)(H,37,40)	SVZMICDKZHCUJL-UHFFFAOYSA-N	644764	US11866450, Compound 178::US11866450, Compound 177	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644764	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644764&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400272	490947047							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365282	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](CCC2C3(CC3)C22CC2)C1=O |r|	InChI=1S/C33H42N6O4S/c1-31(2)19-21-5-4-17-34-25-6-3-7-27(35-25)44(42,43)37-29(40)23-9-11-26(36-28(23)39(31)20-21)38-18-12-22(30(38)41)8-10-24-32(13-14-32)33(24)15-16-33/h3,6-7,9,11,21-22,24H,4-5,8,10,12-20H2,1-2H3,(H,34,35)(H,37,40)	SVZMICDKZHCUJL-UHFFFAOYSA-N	644764	US11866450, Compound 178::US11866450, Compound 177	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644764	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644764&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400272	490947047							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365283	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCC2C3(CC3)C22CC2)C1=O |r|	InChI=1S/C33H42N6O5S/c1-31(2)19-21-5-4-16-34-25-6-3-7-27(35-25)45(42,43)37-29(40)22-8-9-26(36-28(22)39(31)20-21)38-17-10-23(30(38)41)44-18-11-24-32(12-13-32)33(24)14-15-33/h3,6-9,21,23-24H,4-5,10-20H2,1-2H3,(H,34,35)(H,37,40)	QVUOPJBQBOJJOB-UHFFFAOYSA-N	644766	US11866450, Compound 180::US11866450, Compound 179	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644766	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644766&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400217	490947048							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365284	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCC2C3(CC3)C22CC2)C1=O |r|	InChI=1S/C33H42N6O5S/c1-31(2)19-21-5-4-16-34-25-6-3-7-27(35-25)45(42,43)37-29(40)22-8-9-26(36-28(22)39(31)20-21)38-17-10-23(30(38)41)44-18-11-24-32(12-13-32)33(24)14-15-33/h3,6-9,21,23-24H,4-5,10-20H2,1-2H3,(H,34,35)(H,37,40)	QVUOPJBQBOJJOB-UHFFFAOYSA-N	644766	US11866450, Compound 180::US11866450, Compound 179	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644766	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644766&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400217	490947048							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365285	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)N1CC[C@H](CCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C29H37F3N6O4S/c1-27(2)17-19-5-4-14-36-15-10-23(34-36)43(41,42)35-25(39)21-7-8-22(33-24(21)38(27)18-19)37-16-9-20(26(37)40)6-3-11-28(12-13-28)29(30,31)32/h7-8,10,15,19-20H,3-6,9,11-14,16-18H2,1-2H3,(H,35,39)	DDRFJLXVCKJCHW-UHFFFAOYSA-N	644768	US11866450, Compound 182::US11866450, Compound 181	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644768	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644768&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400194	490947049							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365286	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)N1CC[C@H](CCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C29H37F3N6O4S/c1-27(2)17-19-5-4-14-36-15-10-23(34-36)43(41,42)35-25(39)21-7-8-22(33-24(21)38(27)18-19)37-16-9-20(26(37)40)6-3-11-28(12-13-28)29(30,31)32/h7-8,10,15,19-20H,3-6,9,11-14,16-18H2,1-2H3,(H,35,39)	DDRFJLXVCKJCHW-UHFFFAOYSA-N	644768	US11866450, Compound 182::US11866450, Compound 181	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644768	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644768&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400194	490947049							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365287	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)N1CCC(OCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C28H35F3N6O5S/c1-26(2)16-18-4-3-12-35-13-8-22(33-35)43(40,41)34-24(38)19-5-6-21(32-23(19)37(26)17-18)36-14-7-20(25(36)39)42-15-11-27(9-10-27)28(29,30)31/h5-6,8,13,18,20H,3-4,7,9-12,14-17H2,1-2H3,(H,34,38)	DWLGPVWCQYWDOE-UHFFFAOYSA-N	644770	US11866450, Compound 183	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644770	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644770&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400330	490947050							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365288	CC(C)(C)CCC1CCN(C1=O)c1ccc2c(n1)N1C[C@@H](CC1(C)C)CCCn1ccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C28H40N6O4S/c1-27(2,3)13-10-20-11-16-33(26(20)36)22-9-8-21-24(29-22)34-18-19(17-28(34,4)5)7-6-14-32-15-12-23(30-32)39(37,38)31-25(21)35/h8-9,12,15,19-20H,6-7,10-11,13-14,16-18H2,1-5H3,(H,31,35)	ZPDCOMUEAHPALV-UHFFFAOYSA-N	644771	Preparation of 4-[3-(3,3-dimethylbutyl)-2-oxopyrrolidin-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 184	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644771	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644771&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400197	490947051							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365289	CC1(C)C(CCOc2ccn(n2)-c2ccc3c(n2)N2C[C@H](CC2(C)C)CCCNc2cccc(n2)S(=O)(=O)NC3=O)C1(C)C |r|	InChI=1S/C32H43N7O4S/c1-30(2)19-21-9-8-16-33-24-10-7-11-27(34-24)44(41,42)37-29(40)22-12-13-25(35-28(22)38(30)20-21)39-17-14-26(36-39)43-18-15-23-31(3,4)32(23,5)6/h7,10-14,17,21,23H,8-9,15-16,18-20H2,1-6H3,(H,33,34)(H,37,40)	QZVMQMDRULQORH-UHFFFAOYSA-N	644772	Preparation of (14S)-12,12-dimethyl-8-{3-[2-(2,2,3,3-tetramethylcyclopropyl)ethoxy]-1H-pyrazol-1-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione ::US11866450, Compound 185	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644772	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644772&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399885	490947052							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365290	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C30H37N7O4S/c1-28(2)18-20-4-3-14-35-15-8-25(33-35)42(39,40)34-27(38)21-5-6-23(31-26(21)36(28)19-20)37-16-7-24(32-37)41-17-9-22-29(10-11-29)30(22)12-13-30/h5-8,15-16,20,22H,3-4,9-14,17-19H2,1-2H3,(H,34,38)	WNQPJIPCJFYVHJ-UHFFFAOYSA-N	644773	Preparation of (18R)-4-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione ::US11866450, Compound 186	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644773	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644773&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400267	490947053							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365291	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C30H37N7O4S/c1-28(2)18-20-4-3-14-35-15-8-25(33-35)42(39,40)34-27(38)21-5-6-23(31-26(21)36(28)19-20)37-16-7-24(32-37)41-17-9-22-29(10-11-29)30(22)12-13-30/h5-8,15-16,20,22H,3-4,9-14,17-19H2,1-2H3,(H,34,38)	WNQPJIPCJFYVHJ-UHFFFAOYSA-N	644774	US11866450, Compound 187::Preparation of (18S)-4-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-20,20-dimethyl-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644774	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644774&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400207	490947054							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365292	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1	InChI=1S/C31H37N7O5S/c1-29(2)18-20-19-37(29)27-21(28(39)36-44(40,41)26-5-3-4-23(33-26)32-14-17-42-20)6-7-24(34-27)38-15-8-25(35-38)43-16-9-22-30(10-11-30)31(22)12-13-31/h3-8,15,20,22H,9-14,16-19H2,1-2H3,(H,32,33)(H,36,39)	KUHVHEMRJJSJRP-UHFFFAOYSA-N	644775	US11866450, Compound 188	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644775	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644775&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399839	490947055							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365293	CN1CCCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc1n3)-n1ccc(OCCC(C3CC3)C3CC3)n1)C(C)(C)C2	InChI=1S/C33H43N7O4S/c1-33(2)20-22-6-5-17-38(3)27-7-4-8-30(34-27)45(42,43)37-32(41)26-13-14-28(35-31(26)39(33)21-22)40-18-15-29(36-40)44-19-16-25(23-9-10-23)24-11-12-24/h4,7-8,13-15,18,22-25H,5-6,9-12,16-17,19-21H2,1-3H3,(H,37,41)	CWMBUSXKPSNYAL-UHFFFAOYSA-N	644776	US11866450, Compound 189::Preparation of 8-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-12,12,18-trimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644776	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644776&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399857	490947056							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365294	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-4-15-34-22-7-3-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-5-12-29(13-14-29)30(31,32)33/h3,7-11,16,20H,4-6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	GKMTUBDABPEEBO-UHFFFAOYSA-N	644777	US11866450, Compound 190::Preparation of (14R)-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl)cyclo propyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644777	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644777&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400210	490947057							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365295	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)N1CC[C@H](OCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C28H35F3N6O5S/c1-26(2)16-18-4-3-12-35-13-8-22(33-35)43(40,41)34-24(38)19-5-6-21(32-23(19)37(26)17-18)36-14-7-20(25(36)39)42-15-11-27(9-10-27)28(29,30)31/h5-6,8,13,18,20H,3-4,7,9-12,14-17H2,1-2H3,(H,34,38)	DWLGPVWCQYWDOE-UHFFFAOYSA-N	644778	US11866450, Compound 192::US11866450, Compound 191	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644778	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644778&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400213	490947058							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365296	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCC2)n1)N1CC[C@H](OCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C28H35F3N6O5S/c1-26(2)16-18-4-3-12-35-13-8-22(33-35)43(40,41)34-24(38)19-5-6-21(32-23(19)37(26)17-18)36-14-7-20(25(36)39)42-15-11-27(9-10-27)28(29,30)31/h5-6,8,13,18,20H,3-4,7,9-12,14-17H2,1-2H3,(H,34,38)	DWLGPVWCQYWDOE-UHFFFAOYSA-N	644778	US11866450, Compound 192::US11866450, Compound 191	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644778	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644778&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400213	490947058							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365297	CC(C)(C)CCCN1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H43N7O4S/c1-29(2,3)14-8-16-35-17-18-36(28(35)39)24-13-12-22-26(33-24)37-20-21(19-30(37,4)5)9-7-15-31-23-10-6-11-25(32-23)42(40,41)34-27(22)38/h6,10-13,21H,7-9,14-20H2,1-5H3,(H,31,32)(H,34,38)	CVCUBWMJFGZXIT-UHFFFAOYSA-N	644780	US11866450, Compound 193::Preparation of (14S)-8-[3-(4,4-dimethylpentyl)-2-oxoimidazolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644780	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644780&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399771	490947059							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365298	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644781	US11866450, Compound 194::Preparation of (14R)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644781	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644781&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400306	490947060							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365299	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365300	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C31H37N7O5S/c1-29(2)18-20-19-37(29)27-21(28(39)36-44(40,41)26-5-3-4-23(33-26)32-14-17-42-20)6-7-24(34-27)38-15-8-25(35-38)43-16-9-22-30(10-11-30)31(22)12-13-31/h3-8,15,20,22H,9-14,16-19H2,1-2H3,(H,32,33)(H,36,39)	KUHVHEMRJJSJRP-UHFFFAOYSA-N	644783	US11866450, Compound 197::US11866450, Compound 196	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644783	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644783&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400301	490947062							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365301	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCO2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C31H37N7O5S/c1-29(2)18-20-19-37(29)27-21(28(39)36-44(40,41)26-5-3-4-23(33-26)32-14-17-42-20)6-7-24(34-27)38-15-8-25(35-38)43-16-9-22-30(10-11-30)31(22)12-13-31/h3-8,15,20,22H,9-14,16-19H2,1-2H3,(H,32,33)(H,36,39)	KUHVHEMRJJSJRP-UHFFFAOYSA-N	644783	US11866450, Compound 197::US11866450, Compound 196	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644783	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644783&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400301	490947062							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365302	Cc1cn2CCCC3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1n2)-n1ccc(OCCC2(CC2)C(F)(F)F)n1)C(C)(C)C3	InChI=1S/C28H34F3N7O4S/c1-18-16-36-12-4-5-19-15-26(2,3)37(17-19)23-20(24(39)35-43(40,41)25(18)34-36)6-7-21(32-23)38-13-8-22(33-38)42-14-11-27(9-10-27)28(29,30)31/h6-8,13,16,19H,4-5,9-12,14-15,17H2,1-3H3,(H,35,39)	WRFAYNKIRPKPSI-UHFFFAOYSA-N	644785	US11866450, Compound 199::Preparation of 12,20,20-trimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2(7),3,5,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644785	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644785&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400083	490947063							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365303	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(C2CCCCC2)C1=O |r|	InChI=1S/C29H39N7O4S/c1-29(2)18-20-8-7-15-30-23-11-6-12-25(31-23)41(39,40)33-27(37)22-13-14-24(32-26(22)36(29)19-20)35-17-16-34(28(35)38)21-9-4-3-5-10-21/h6,11-14,20-21H,3-5,7-10,15-19H2,1-2H3,(H,30,31)(H,33,37)	OBXLNHLRMAGILM-UHFFFAOYSA-N	644786	US11866450, Compound 200::Preparation of (14S)-8-(3-cyclohexyl-2-oxoimidazolidin-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644786	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644786&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400095	490947064							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365304	Cc1cn2CCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1n2)-n1ccc(OCCC(C2CC2)C2CC2)n1)C(C)(C)C3 |r|	InChI=1S/C31H41N7O4S/c1-20-18-36-14-4-5-21-17-31(2,3)37(19-21)28-25(29(39)35-43(40,41)30(20)34-36)10-11-26(32-28)38-15-12-27(33-38)42-16-13-24(22-6-7-22)23-8-9-23/h10-12,15,18,21-24H,4-9,13-14,16-17,19H2,1-3H3,(H,35,39)	AMNBJSIEHYUXTP-UHFFFAOYSA-N	644787	US11866450, Compound 202::US11866450, Compound 201	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644787	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644787&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400257	490947065							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365305	Cc1cn2CCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1n2)-n1ccc(OCCC(C2CC2)C2CC2)n1)C(C)(C)C3 |r|	InChI=1S/C31H41N7O4S/c1-20-18-36-14-4-5-21-17-31(2,3)37(19-21)28-25(29(39)35-43(40,41)30(20)34-36)10-11-26(32-28)38-15-12-27(33-38)42-16-13-24(22-6-7-22)23-8-9-23/h10-12,15,18,21-24H,4-9,13-14,16-17,19H2,1-3H3,(H,35,39)	AMNBJSIEHYUXTP-UHFFFAOYSA-N	644787	US11866450, Compound 202::US11866450, Compound 201	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644787	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644787&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400257	490947065							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365306	CN1CCC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc1n3)-n1ccc(OCCC(C3CC3)C3CC3)n1)C(C)(C)C2 |r|	InChI=1S/C33H43N7O4S/c1-33(2)20-22-6-5-17-38(3)27-7-4-8-30(34-27)45(42,43)37-32(41)26-13-14-28(35-31(26)39(33)21-22)40-18-15-29(36-40)44-19-16-25(23-9-10-23)24-11-12-24/h4,7-8,13-15,18,22-25H,5-6,9-12,16-17,19-21H2,1-3H3,(H,37,41)	CWMBUSXKPSNYAL-UHFFFAOYSA-N	644789	US11866450, Compound 204::US11866450, Compound 203	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644789	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644789&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400214	490947066							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365307	CN1CCC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc1n3)-n1ccc(OCCC(C3CC3)C3CC3)n1)C(C)(C)C2 |r|	InChI=1S/C33H43N7O4S/c1-33(2)20-22-6-5-17-38(3)27-7-4-8-30(34-27)45(42,43)37-32(41)26-13-14-28(35-31(26)39(33)21-22)40-18-15-29(36-40)44-19-16-25(23-9-10-23)24-11-12-24/h4,7-8,13-15,18,22-25H,5-6,9-12,16-17,19-21H2,1-3H3,(H,37,41)	CWMBUSXKPSNYAL-UHFFFAOYSA-N	644789	US11866450, Compound 204::US11866450, Compound 203	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644789	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644789&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400214	490947066							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365308	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(CCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C30H38F3N7O4S/c1-28(2)18-20-6-4-14-34-22-7-3-8-24(35-22)45(43,44)37-26(41)21-9-10-23(36-25(21)40(28)19-20)39-17-16-38(27(39)42)15-5-11-29(12-13-29)30(31,32)33/h3,7-10,20H,4-6,11-19H2,1-2H3,(H,34,35)(H,37,41)	VYFWZCUHNMETRJ-UHFFFAOYSA-N	644791	US11866450, Compound 205::Preparation of (14S)-12,12-dimethyl-8-(2-oxo-3-{3-[1-(trifluoromethyl)cyclopropyl]propyl}imidazolidin-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644791	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644791&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400063	490947067							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365309	CC1(C)C(CCOc2ccn(n2)-c2ccc3c(n2)N2C[C@@H](CC2(C)C)CCCn2ccc(n2)S(=O)(=O)NC3=O)C1(C)C |r|	InChI=1S/C30H41N7O4S/c1-28(2)18-20-8-7-14-35-15-12-25(33-35)42(39,40)34-27(38)21-9-10-23(31-26(21)36(28)19-20)37-16-11-24(32-37)41-17-13-22-29(3,4)30(22,5)6/h9-12,15-16,20,22H,7-8,13-14,17-19H2,1-6H3,(H,34,38)	NYEVOSFUKSSOQC-UHFFFAOYSA-N	644792	US11866450, Compound 207::US11866450, Compound 206	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644792	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644792&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400285	490947068							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365310	CC1(C)C(CCOc2ccn(n2)-c2ccc3c(n2)N2C[C@@H](CC2(C)C)CCCn2ccc(n2)S(=O)(=O)NC3=O)C1(C)C |r|	InChI=1S/C30H41N7O4S/c1-28(2)18-20-8-7-14-35-15-12-25(33-35)42(39,40)34-27(38)21-9-10-23(31-26(21)36(28)19-20)37-16-11-24(32-37)41-17-13-22-29(3,4)30(22,5)6/h9-12,15-16,20,22H,7-8,13-14,17-19H2,1-6H3,(H,34,38)	NYEVOSFUKSSOQC-UHFFFAOYSA-N	644792	US11866450, Compound 207::US11866450, Compound 206	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644792	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644792&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400285	490947068							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365311	CC(C)(COc1ccn(n1)-c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(F)(F)F |r|	InChI=1S/C28H34F3N7O4S/c1-26(2,28(29,30)31)17-42-22-12-14-38(35-22)21-11-10-19-24(34-21)37-16-18(15-27(37,3)4)7-6-13-32-20-8-5-9-23(33-20)43(40,41)36-25(19)39/h5,8-12,14,18H,6-7,13,15-17H2,1-4H3,(H,32,33)(H,36,39)	JVYVFBBSEGVQFR-UHFFFAOYSA-N	644794	US11866450, Compound 208::Preparation of (14S)-12,12-dimethyl-8-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644794	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644794&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399958	490947069							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365312	CC1CCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)N1CCN(CCC(C)(C)C)C1=O)C(C)(C)C2	InChI=1S/C30H43N7O4S/c1-20-10-11-21-18-30(5,6)37(19-21)26-22(27(38)34-42(40,41)25-9-7-8-23(31-20)32-25)12-13-24(33-26)36-17-16-35(28(36)39)15-14-29(2,3)4/h7-9,12-13,20-21H,10-11,14-19H2,1-6H3,(H,31,32)(H,34,38)	NMDKHIXTJLXVDL-UHFFFAOYSA-N	644795	US11866450, Compound 210::US11866450, Compound 209	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644795	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644795&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399858	490947070							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365313	CC1CCC2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)N1CCN(CCC(C)(C)C)C1=O)C(C)(C)C2	InChI=1S/C30H43N7O4S/c1-20-10-11-21-18-30(5,6)37(19-21)26-22(27(38)34-42(40,41)25-9-7-8-23(31-20)32-25)12-13-24(33-26)36-17-16-35(28(36)39)15-14-29(2,3)4/h7-9,12-13,20-21H,10-11,14-19H2,1-6H3,(H,31,32)(H,34,38)	NMDKHIXTJLXVDL-UHFFFAOYSA-N	644795	US11866450, Compound 210::US11866450, Compound 209	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644795	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644795&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399858	490947070							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365314	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(CCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C29H36F3N7O4S/c1-27(2)17-19-5-4-13-33-21-6-3-7-23(34-21)44(42,43)36-25(40)20-8-9-22(35-24(20)39(27)18-19)38-16-15-37(26(38)41)14-12-28(10-11-28)29(30,31)32/h3,6-9,19H,4-5,10-18H2,1-2H3,(H,33,34)(H,36,40)	JPRIXXLZYUNHIE-UHFFFAOYSA-N	644797	US11866450, Compound 211::Preparation of (14S)-12,12-dimethyl-8-(2-oxo-3-{2-[1-(trifluoromethyl)cyclopropyl]ethyl}imidazolidin-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644797	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644797&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400087	490947071							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365315	CC(C)(CCOc1ccn(n1)-c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(F)(F)F |r|	InChI=1S/C29H36F3N7O4S/c1-27(2,29(30,31)32)13-16-43-23-12-15-39(36-23)22-11-10-20-25(35-22)38-18-19(17-28(38,3)4)7-6-14-33-21-8-5-9-24(34-21)44(41,42)37-26(20)40/h5,8-12,15,19H,6-7,13-14,16-18H2,1-4H3,(H,33,34)(H,37,40)	XKQWNKLFIOFERL-UHFFFAOYSA-N	644798	US11866450, Compound 212::Preparation of (14S)-12,12-dimethyl-8-[3-(4,4,4-trifluoro-3,3-dimethylbutoxy)-1H-pyrazol-1-yl]-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644798	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644798&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400017	490947072							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365316	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC2CCCCN2C1=O |r|	InChI=1S/C27H35N7O4S/c1-27(2)15-18-7-6-13-28-21-9-5-10-23(29-21)39(37,38)31-25(35)20-11-12-22(30-24(20)34(27)16-18)33-17-19-8-3-4-14-32(19)26(33)36/h5,9-12,18-19H,3-4,6-8,13-17H2,1-2H3,(H,28,29)(H,31,35)	FICHHQXIPKHVHC-UHFFFAOYSA-N	644799	US11866450, Compound 213::Preparation of (14S)-12,12-dimethyl-8-{3-oxo-octahydroimidazo[1,5-a]pyridin-2-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644799	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644799&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400091	490947073							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365317	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(CC2CCC(F)(F)CC2)C1=O |r|	InChI=1S/C30H39F2N7O4S/c1-29(2)17-21-5-4-14-33-23-6-3-7-25(34-23)44(42,43)36-27(40)22-8-9-24(35-26(22)39(29)19-21)38-16-15-37(28(38)41)18-20-10-12-30(31,32)13-11-20/h3,6-9,20-21H,4-5,10-19H2,1-2H3,(H,33,34)(H,36,40)	OLNKELKUFCVZFA-UHFFFAOYSA-N	644800	US11866450, Compound 214::Preparation of (14S)-8-{3-[(4,4-difluorocyclohexyl)methyl]-2-oxoimidazolidin-1-yl}-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644800	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644800&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400107	490947074							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365318	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)N1CCN(CCC(C)(C)C)C1=O)C(C)(C)C2 |r|	InChI=1S/C30H43N7O4S/c1-20-10-11-21-18-30(5,6)37(19-21)26-22(27(38)34-42(40,41)25-9-7-8-23(31-20)32-25)12-13-24(33-26)36-17-16-35(28(36)39)15-14-29(2,3)4/h7-9,12-13,20-21H,10-11,14-19H2,1-6H3,(H,31,32)(H,34,38)	NMDKHIXTJLXVDL-UHFFFAOYSA-N	644801	US11866450, Compound 218::US11866450, Compound 219::US11866450, Compound 216::US11866450, Compound 215	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644801	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644801&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400293	490947075							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365319	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)N1CCN(CCC(C)(C)C)C1=O)C(C)(C)C2 |r|	InChI=1S/C30H43N7O4S/c1-20-10-11-21-18-30(5,6)37(19-21)26-22(27(38)34-42(40,41)25-9-7-8-23(31-20)32-25)12-13-24(33-26)36-17-16-35(28(36)39)15-14-29(2,3)4/h7-9,12-13,20-21H,10-11,14-19H2,1-6H3,(H,31,32)(H,34,38)	NMDKHIXTJLXVDL-UHFFFAOYSA-N	644801	US11866450, Compound 218::US11866450, Compound 219::US11866450, Compound 216::US11866450, Compound 215	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644801	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644801&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400293	490947075							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365320	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(CC2CCC(C)(C)CC2)C1=O |r|	InChI=1S/C32H45N7O4S/c1-31(2)14-12-22(13-15-31)20-37-17-18-38(30(37)41)26-11-10-24-28(35-26)39-21-23(19-32(39,3)4)7-6-16-33-25-8-5-9-27(34-25)44(42,43)36-29(24)40/h5,8-11,22-23H,6-7,12-21H2,1-4H3,(H,33,34)(H,36,40)	GVLAYIKNDGBFPR-UHFFFAOYSA-N	644803	US11866450, Compound 217::Preparation of (14S)-8-{3-[(4,4-dimethylcyclohexyl)methyl]-2-oxoimidazolidin-1-yl}-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644803	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644803&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399883	490947076							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365321	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)N1CCN(CCC(C)(C)C)C1=O)C(C)(C)C2 |r|	InChI=1S/C30H43N7O4S/c1-20-10-11-21-18-30(5,6)37(19-21)26-22(27(38)34-42(40,41)25-9-7-8-23(31-20)32-25)12-13-24(33-26)36-17-16-35(28(36)39)15-14-29(2,3)4/h7-9,12-13,20-21H,10-11,14-19H2,1-6H3,(H,31,32)(H,34,38)	NMDKHIXTJLXVDL-UHFFFAOYSA-N	644801	US11866450, Compound 218::US11866450, Compound 219::US11866450, Compound 216::US11866450, Compound 215	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644801	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644801&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400293	490947075							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365322	C[C@@H]1CC[C@H]2CN(c3nc(ccc3C(=O)NS(=O)(=O)c3cccc(N1)n3)N1CCN(CCC(C)(C)C)C1=O)C(C)(C)C2 |r|	InChI=1S/C30H43N7O4S/c1-20-10-11-21-18-30(5,6)37(19-21)26-22(27(38)34-42(40,41)25-9-7-8-23(31-20)32-25)12-13-24(33-26)36-17-16-35(28(36)39)15-14-29(2,3)4/h7-9,12-13,20-21H,10-11,14-19H2,1-6H3,(H,31,32)(H,34,38)	NMDKHIXTJLXVDL-UHFFFAOYSA-N	644801	US11866450, Compound 218::US11866450, Compound 219::US11866450, Compound 216::US11866450, Compound 215	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644801	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644801&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400293	490947075							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365323	CC(C)C(COc1ccn(n1)-c1ccc2c(n1)N1CC(CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(C)C	InChI=1S/C31H43N7O4S/c1-20(2)24(21(3)4)19-42-27-14-16-38(35-27)26-13-12-23-29(34-26)37-18-22(17-31(37,5)6)9-8-15-32-25-10-7-11-28(33-25)43(40,41)36-30(23)39/h7,10-14,16,20-22,24H,8-9,15,17-19H2,1-6H3,(H,32,33)(H,36,39)	NGRNSRUKUYCNID-UHFFFAOYSA-N	644806	US11866450, Compound 220::Preparation of 12,12-dimethyl-8-{3-[3-methyl-2-(propan-2-yl)butoxy]-1H-pyrazol-1-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644806	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644806&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400037	490947077							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365324	CC(C)(CCOc1ccn(n1)-c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCn1ccc(n1)S(=O)(=O)NC2=O)C(F)(F)F |r|	InChI=1S/C27H34F3N7O4S/c1-25(2,27(28,29)30)11-15-41-21-9-14-37(32-21)20-8-7-19-23(31-20)36-17-18(16-26(36,3)4)6-5-12-35-13-10-22(33-35)42(39,40)34-24(19)38/h7-10,13-14,18H,5-6,11-12,15-17H2,1-4H3,(H,34,38)	MPTUBLDKYXSJIR-UHFFFAOYSA-N	644807	US11866450, Compound 221::Preparation of (18S)-20,20-dimethyl-4-[3-(4,4,4-trifluoro-3,3-dimethylbutoxy)-1H-pyrazol-1-yl]-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644807	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644807&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399891	490947078							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365325	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCC2(CCCCC2)C1=O |r|	InChI=1S/C29H38N6O4S/c1-28(2)18-20-8-7-16-30-22-9-6-10-24(31-22)40(38,39)33-26(36)21-11-12-23(32-25(21)35(28)19-20)34-17-15-29(27(34)37)13-4-3-5-14-29/h6,9-12,20H,3-5,7-8,13-19H2,1-2H3,(H,30,31)(H,33,36)	SPZCVCSDPFHBAO-UHFFFAOYSA-N	644808	US11866450, Compound 222::Preparation of (14S)-12,12-dimethyl-8-{1-oxo-2-azaspiro[4.5]decan-2-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644808	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644808&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400249	490947079							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365326	CC(C)(CCN1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(F)(F)F |r|	InChI=1S/C29H38F3N7O4S/c1-27(2,29(30,31)32)12-14-37-15-16-38(26(37)41)22-11-10-20-24(35-22)39-18-19(17-28(39,3)4)7-6-13-33-21-8-5-9-23(34-21)44(42,43)36-25(20)40/h5,8-11,19H,6-7,12-18H2,1-4H3,(H,33,34)(H,36,40)	OPMKMPCULIKBJI-UHFFFAOYSA-N	644809	US11866450, Compound 223::Preparation of (14S)-12,12-dimethyl-8-[2-oxo-3-(4,4,4-trifluoro-3,3-dimethylbutyl)imidazolidin-1-yl]-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644809	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644809&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399861	490947080							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365327	CC(C)COc1cc(F)cc(c1)-c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C30H36FN5O4S/c1-19(2)18-40-23-14-21(13-22(31)15-23)25-11-10-24-28(33-25)36-17-20(16-30(36,3)4)7-6-12-32-26-8-5-9-27(34-26)41(38,39)35-29(24)37/h5,8-11,13-15,19-20H,6-7,12,16-18H2,1-4H3,(H,32,34)(H,35,37)	JVZVPPMGDXXODK-UHFFFAOYSA-N	644810	US11866450, Compound 224::Preparation of (14S)-8-[3-fluoro-5-(2-methylpropoxy)phenyl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644810	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644810&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399907	490947081							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365328	CC(C)(CN1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(F)(F)F |r|	InChI=1S/C28H36F3N7O4S/c1-26(2,28(29,30)31)17-36-13-14-37(25(36)40)21-11-10-19-23(34-21)38-16-18(15-27(38,3)4)7-6-12-32-20-8-5-9-22(33-20)43(41,42)35-24(19)39/h5,8-11,18H,6-7,12-17H2,1-4H3,(H,32,33)(H,35,39)	IYIZJRFKZMZTDZ-UHFFFAOYSA-N	644811	US11866450, Compound 225::Preparation of (14S)-12,12-dimethyl-8-[2-oxo-3-(3,3,3-trifluoro-2,2-dimethylpropyl)imidazolidin-1-yl]-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644811	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644811&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400190	490947082							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365329	CC(C)COc1cc(F)cc(c1)-c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCn1ccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C28H34FN5O4S/c1-18(2)17-38-22-13-20(12-21(29)14-22)24-8-7-23-26(30-24)34-16-19(15-28(34,3)4)6-5-10-33-11-9-25(31-33)39(36,37)32-27(23)35/h7-9,11-14,18-19H,5-6,10,15-17H2,1-4H3,(H,32,35)	KOGUEEGOALHJMZ-UHFFFAOYSA-N	644812	US11866450, Compound 226	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644812	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644812&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399897	490947083							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365330	CC(C)C(COc1ccn(n1)-c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(C)C |r|	InChI=1S/C31H43N7O4S/c1-20(2)24(21(3)4)19-42-27-14-16-38(35-27)26-13-12-23-29(34-26)37-18-22(17-31(37,5)6)9-8-15-32-25-10-7-11-28(33-25)43(40,41)36-30(23)39/h7,10-14,16,20-22,24H,8-9,15,17-19H2,1-6H3,(H,32,33)(H,36,39)	NGRNSRUKUYCNID-UHFFFAOYSA-N	644813	US11866450, Compound 227::Preparation of (14S)-12,12-dimethyl-8-{3-[3-methyl-2-(propan-2-yl)butoxy]-1H-pyrazol-1-yl}-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644813	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644813&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399928	490947084							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365331	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(CCC23CC4CC(CC(C4)C2)C3)C1=O |r,TLB:34:35:38:41.42.40,42:41:44:38.37.36,42:37:44:41.43.40,THB:43:41:38:44.35.36,43:35:38:41.42.40|			644814	US11866450, Compound 228::Preparation of (14S)-8-{3-[2-(adamantan-1-yl)ethyl]-2-oxoimidazolidin-1-yl}-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644814	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644814&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399900	490947085							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365332	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(CC23CC4CC(CC(C4)C2)C3)C1=O |r,TLB:33:34:37:40.41.39,41:40:43:37.36.35,41:36:43:40.42.39,THB:42:40:37:43.34.35,42:34:37:40.41.39|			644815	US11866450, Compound 229::Preparation of (14S)-8-{3-[(adamantan-1-yl)methyl]-2-oxoimidazolidin-1-yl}-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644815	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644815&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400109	490947086							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365333	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(C1=O)C12CC3CC(CC(C3)C1)C2 |r,TLB:32:35:38:41.42.40,42:41:44:38.37.36,42:37:44:41.43.40,THB:43:41:38:44.35.36,43:35:38:41.42.40|			644816	US11866450, Compound 230::Preparation of (14S)-8-[3-(adamantan-1-yl)-2-oxoimidazolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644816	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644816&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399940	490947087							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365334	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC(C2CCC2)C2CCC2)n1 |r|	InChI=1S/C34H45N7O4S/c1-34(2)21-23-7-6-18-35-28-12-5-13-31(36-28)46(43,44)39-33(42)27-14-15-29(37-32(27)40(34)22-23)41-19-16-30(38-41)45-20-17-26(24-8-3-9-24)25-10-4-11-25/h5,12-16,19,23-26H,3-4,6-11,17-18,20-22H2,1-2H3,(H,35,36)(H,39,42)	IWVCKBJBGZJNGG-UHFFFAOYSA-N	644817	US11866450, Compound 231::Preparation of (14S)-8-[3-(3,3-dicyclobutylpropoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644817	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644817&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399875	490947088							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365335	CC(C)(C)CCN1CCN(C1=O)c1ccc2c(n1)N1C(CCC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O	InChI=1S/C29H41N7O4S/c1-28(2,3)15-17-34-18-19-35(27(34)38)23-12-11-21-25(32-23)36-20(13-14-29(36,4)5)8-7-16-30-22-9-6-10-24(31-22)41(39,40)33-26(21)37/h6,9-12,20H,7-8,13-19H2,1-5H3,(H,30,31)(H,33,37)	MZVSKRZNUYLMRX-UHFFFAOYSA-N	644818	US11866450, Compound 232::Preparation of 8-[3-(3,3-dimethylbutyl)-2-oxoimidazolidin-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,19,24-pentaazatetracyclo[18.3.1.05,10.011,15]tetracosa-1(23),5,7,9,20(24),21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644818	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644818&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400126	490947089							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365336	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-9-14-33-21-5-3-6-24(34-21)44(41,42)37-26(40)20-7-8-22(35-25(20)38(27)18-19)39-15-10-23(36-39)43-16-4-11-28(12-13-28)29(30,31)32/h3,5-8,10,15,19H,4,9,11-14,16-18H2,1-2H3,(H,33,34)(H,37,40)	QZIDCUNNTYVZEW-UHFFFAOYSA-N	644819	US11866450, Compound 235::US11866450, Compound 234	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644819	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644819&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400208	490947090							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365337	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H34F3N7O4S/c1-27(2)17-19-9-14-33-21-5-3-6-24(34-21)44(41,42)37-26(40)20-7-8-22(35-25(20)38(27)18-19)39-15-10-23(36-39)43-16-4-11-28(12-13-28)29(30,31)32/h3,5-8,10,15,19H,4,9,11-14,16-18H2,1-2H3,(H,33,34)(H,37,40)	QZIDCUNNTYVZEW-UHFFFAOYSA-N	644819	US11866450, Compound 235::US11866450, Compound 234	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644819	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644819&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400208	490947090							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365338	CC1(C)C2CCN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N7O4S/c1-26(2)18-8-14-32-20-4-3-5-23(33-20)43(40,41)36-25(39)19-6-7-21(34-24(19)37(26)15-9-18)38-16-10-22(35-38)42-17-13-27(11-12-27)28(29,30)31/h3-7,10,16,18H,8-9,11-15,17H2,1-2H3,(H,32,33)(H,36,39)	JYPOURGVNVHUPJ-UHFFFAOYSA-N	644821	US11866450, Compound 236::Preparation of 23,23-dimethyl-11-(3-{2-[1-(trifluoromethyl)cyclo propyl]ethoxy}-1H-pyrazol-1-yl)-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.15,8.09,14]tricosa-1(22),9,11,13,18,20-hexaene-15,17,17-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644821	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644821&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400114	490947091							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365339	CC(C)(CCOC1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O)C(F)(F)F |r|	InChI=1S/C30H39F3N6O5S/c1-28(2,30(31,32)33)13-16-44-21-12-15-38(27(21)41)23-11-10-20-25(36-23)39-18-19(17-29(39,3)4)7-6-14-34-22-8-5-9-24(35-22)45(42,43)37-26(20)40/h5,8-11,19,21H,6-7,12-18H2,1-4H3,(H,34,35)(H,37,40)	QHOYOELOBYFUFN-UHFFFAOYSA-N	644822	US11866450, Compound 237::Preparation of (14S)-12,12-dimethyl-8-[2-oxo-3-(4,4,4-trifluoro-3,3-dimethylbutoxy)pyrrolidin-1-yl]-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644822	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644822&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399909	490947092							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365340	CC(C)C(COc1ccn(n1)-c1ccc2c(n1)N1CC(CC1(C)C)OCCNc1cccc(n1)S(=O)(=O)NC2=O)C(C)C	InChI=1S/C30H41N7O5S/c1-19(2)23(20(3)4)18-42-26-12-14-37(34-26)25-11-10-22-28(33-25)36-17-21(16-30(36,5)6)41-15-13-31-24-8-7-9-27(32-24)43(39,40)35-29(22)38/h7-12,14,19-21,23H,13,15-18H2,1-6H3,(H,31,32)(H,35,38)	CPSQMVJHLNSKOJ-UHFFFAOYSA-N	644823	US11866450, Compound 238::Preparation of 12,12-dimethyl-8-{3-[3-methyl-2-(propan-2-yl)butoxy]-1H-pyrazol-1-yl}-15-oxa-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644823	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644823&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399896	490947093							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365341	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CCN(C[C@H]2CC[C@H](CC2)C(F)(F)F)C1=O |r,wU:4.3,wD:34.37,37.44,(2.26,-.9,;3.6,-.13,;3.6,-1.67,;5.06,-.61,;5.97,.64,;5.06,1.89,;3.6,1.41,;2.26,2.18,;.93,1.41,;-.4,2.18,;-.4,3.72,;.93,4.49,;2.26,3.72,;3.6,4.49,;3.6,6.03,;4.93,3.72,;6.27,4.49,;7.04,5.82,;5.5,5.82,;7.6,3.72,;8.93,4.49,;10.27,3.72,;10.27,2.18,;8.93,1.41,;8.93,-.13,;8.53,-1.62,;7.11,-.85,;7.51,.64,;7.6,2.18,;-1.74,1.41,;-1.74,-.13,;-3.2,-.61,;-4.11,.64,;-5.65,.64,;-6.42,-.69,;-7.96,-.69,;-8.73,-2.03,;-7.96,-3.36,;-6.42,-3.36,;-5.65,-2.03,;-8.73,-4.7,;-7.96,-6.03,;-10.27,-4.7,;-9.5,-6.03,;-3.2,1.89,;-3.6,3.37,)|	InChI=1S/C31H40F3N7O4S/c1-30(2)17-21-5-4-14-35-24-6-3-7-26(36-24)46(44,45)38-28(42)23-12-13-25(37-27(23)41(30)19-21)40-16-15-39(29(40)43)18-20-8-10-22(11-9-20)31(32,33)34/h3,6-7,12-13,20-22H,4-5,8-11,14-19H2,1-2H3,(H,35,36)(H,38,42)	NEEHGWQPPBIMKC-UHFFFAOYSA-N	644824	US11866450, Compound 239::Preparation of (14S)-12,12-dimethyl-8-(2-oxo-3-{[4-(trifluoromethyl)cyclohexyl]methyl}imidazolidin-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644824	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644824&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400229	490947094							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365342	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCC23CC4CC(CC(C4)C2)C3)C1=O |r,TLB:45:36:43:39.40.41,THB:44:36:39:43.42.41,44:42:39:36.45.37,35:36:43:39.40.41,45:40:43:36.44.37|			644825	US11866450, Compound 241::US11866450, Compound 240	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644825	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644825&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400314	490947095							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365343	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCC23CC4CC(CC(C4)C2)C3)C1=O |r,TLB:45:36:43:39.40.41,THB:44:36:39:43.42.41,44:42:39:36.45.37,35:36:43:39.40.41,45:40:43:36.44.37|			644825	US11866450, Compound 241::US11866450, Compound 240	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644825	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644825&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400314	490947095							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365344	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C31H39F3N6O5S/c1-29(2)18-20-6-4-15-35-23-7-3-8-25(36-23)46(43,44)38-27(41)21-9-10-24(37-26(21)40(29)19-20)39-16-11-22(28(39)42)45-17-5-12-30(13-14-30)31(32,33)34/h3,7-10,20,22H,4-6,11-19H2,1-2H3,(H,35,36)(H,38,41)	PSOOSRSQJZLANU-UHFFFAOYSA-N	644827	US11866450, Compound 243::US11866450, Compound 242	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644827	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644827&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400284	490947096							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365345	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCCCC2(CC2)C(F)(F)F)C1=O |r|	InChI=1S/C31H39F3N6O5S/c1-29(2)18-20-6-4-15-35-23-7-3-8-25(36-23)46(43,44)38-27(41)21-9-10-24(37-26(21)40(29)19-20)39-16-11-22(28(39)42)45-17-5-12-30(13-14-30)31(32,33)34/h3,7-10,20,22H,4-6,11-19H2,1-2H3,(H,35,36)(H,38,41)	PSOOSRSQJZLANU-UHFFFAOYSA-N	644827	US11866450, Compound 243::US11866450, Compound 242	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644827	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644827&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400284	490947096							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365346	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCC23CC4CC(CC(C4)C2)C3)C1=O |r,TLB:34:35:38:42.41.40,44:35:42:38.39.40,THB:44:39:42:35.43.36,43:35:38:42.41.40,43:41:38:35.44.36|			644829	US11866450, Compound 245::US11866450, Compound 244	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644829	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644829&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400322	490947097							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365347	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)N1CC[C@H](OCC23CC4CC(CC(C4)C2)C3)C1=O |r,TLB:34:35:38:42.41.40,44:35:42:38.39.40,THB:44:39:42:35.43.36,43:35:38:42.41.40,43:41:38:35.44.36|			644829	US11866450, Compound 245::US11866450, Compound 244	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644829	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644829&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400322	490947097							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365348	CC(C)(C)CCCO[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C31H44N6O5S/c1-30(2,3)15-8-18-42-23-14-17-36(29(23)39)25-13-12-22-27(34-25)37-20-21(19-31(37,4)5)9-7-16-32-24-10-6-11-26(33-24)43(40,41)35-28(22)38/h6,10-13,21,23H,7-9,14-20H2,1-5H3,(H,32,33)(H,35,38)	UUDGITDLWMOYEJ-UHFFFAOYSA-N	644831	US11866450, Compound 247::US11866450, Compound 246	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644831	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644831&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400339	490947098							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365349	CC(C)(C)CCCO[C@H]1CCN(C1=O)c1ccc2c(n1)N1C[C@H](CC1(C)C)CCCNc1cccc(n1)S(=O)(=O)NC2=O |r|	InChI=1S/C31H44N6O5S/c1-30(2,3)15-8-18-42-23-14-17-36(29(23)39)25-13-12-22-27(34-25)37-20-21(19-31(37,4)5)9-7-16-32-24-10-6-11-26(33-24)43(40,41)35-28(22)38/h6,10-13,21,23H,7-9,14-20H2,1-5H3,(H,32,33)(H,35,38)	UUDGITDLWMOYEJ-UHFFFAOYSA-N	644831	US11866450, Compound 247::US11866450, Compound 246	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644831	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644831&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400339	490947098							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365350	CC(C)C(COc1ccn(n1)-c1ccc2c(n1)N1C[C@@H](CC1(C)C)OCCNc1cccc(n1)S(=O)(=O)NC2=O)C(C)C |r|	InChI=1S/C30H41N7O5S/c1-19(2)23(20(3)4)18-42-26-12-14-37(34-26)25-11-10-22-28(33-25)36-17-21(16-30(36,5)6)41-15-13-31-24-8-7-9-27(32-24)43(39,40)35-29(22)38/h7-12,14,19-21,23H,13,15-18H2,1-6H3,(H,31,32)(H,35,38)	CPSQMVJHLNSKOJ-UHFFFAOYSA-N	644833	US11866450, Compound 249::US11866450, Compound 248	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644833	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644833&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400275	490947099							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365351	CC(C)C(COc1ccn(n1)-c1ccc2c(n1)N1C[C@@H](CC1(C)C)OCCNc1cccc(n1)S(=O)(=O)NC2=O)C(C)C |r|	InChI=1S/C30H41N7O5S/c1-19(2)23(20(3)4)18-42-26-12-14-37(34-26)25-11-10-22-28(33-25)36-17-21(16-30(36,5)6)41-15-13-31-24-8-7-9-27(32-24)43(39,40)35-29(22)38/h7-12,14,19-21,23H,13,15-18H2,1-6H3,(H,31,32)(H,35,38)	CPSQMVJHLNSKOJ-UHFFFAOYSA-N	644833	US11866450, Compound 249::US11866450, Compound 248	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644833	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644833&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400275	490947099							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365352	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C31H39N7O4S/c1-31(2)18-20-12-15-32-25-4-3-5-28(33-25)43(40,41)36-30(39)24-10-11-26(34-29(24)37(31)19-20)38-16-13-27(35-38)42-17-14-23(21-6-7-21)22-8-9-22/h3-5,10-11,13,16,20-23H,6-9,12,14-15,17-19H2,1-2H3,(H,32,33)(H,36,39)	NEWUDMJJSJVJJQ-UHFFFAOYSA-N	644835	Preparation of 11-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-7,7-dimethyl-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.15,8.09,14]tricosa-1(22),9,11,13,18,20-hexaene-15,17,17-trione (Enantiomer 2) ::US11866450, Compound 251::US11866450, Compound 250	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644835	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644835&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400226	490947100							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365353	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC2)n1)-n1ccc(OCCC(C2CC2)C2CC2)n1 |r|	InChI=1S/C31H39N7O4S/c1-31(2)18-20-12-15-32-25-4-3-5-28(33-25)43(40,41)36-30(39)24-10-11-26(34-29(24)37(31)19-20)38-16-13-27(35-38)42-17-14-23(21-6-7-21)22-8-9-22/h3-5,10-11,13,16,20-23H,6-9,12,14-15,17-19H2,1-2H3,(H,32,33)(H,36,39)	NEWUDMJJSJVJJQ-UHFFFAOYSA-N	644835	Preparation of 11-[3-(3,3-dicyclopropylpropoxy)-1H-pyrazol-1-yl]-7,7-dimethyl-17&#955;6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.15,8.09,14]tricosa-1(22),9,11,13,18,20-hexaene-15,17,17-trione (Enantiomer 2) ::US11866450, Compound 251::US11866450, Compound 250	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644835	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644835&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400226	490947100							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365354	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365355	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365356	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(O)c(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O5S/c1-30(2)18-20-4-3-15-33-27-22(40)6-8-26(35-27)45(42,43)37-29(41)21-5-7-24(34-28(21)38(30)19-20)39-16-9-25(36-39)44-17-10-23-31(11-12-31)32(23)13-14-32/h5-9,16,20,23,40H,3-4,10-15,17-19H2,1-2H3,(H,33,35)(H,37,41)	CPKOXXVZDLUCSW-UHFFFAOYSA-N	644839	US11866450, Compound 254::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-20-hydroxy-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644839	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644839&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400077	490947101							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365357	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccc(O)c(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)17-19-5-3-14-34-25-21(41)7-9-24(36-25)46(43,44)38-27(42)20-6-8-22(35-26(20)39(28)18-19)40-15-10-23(37-40)45-16-4-11-29(12-13-29)30(31,32)33/h6-10,15,19,41H,3-5,11-14,16-18H2,1-2H3,(H,34,36)(H,38,42)	AQIKAHVDPJOMJK-UHFFFAOYSA-N	644840	US11866450, Compound 255::Preparation of (14S)-20-hydroxy-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644840	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644840&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399952	490947102							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365358	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(O)n1 |r|	InChI=1S/C23H27N7O4S/c1-23(2)13-15-5-4-11-24-17-6-3-7-20(25-17)35(33,34)28-22(32)16-8-9-18(26-21(16)29(23)14-15)30-12-10-19(31)27-30/h3,6-10,12,15H,4-5,11,13-14H2,1-2H3,(H,24,25)(H,27,31)(H,28,32)	PSJSVAFPDPKMGG-UHFFFAOYSA-N	644841	US11866450, Compound 256::Preparation of (14S)-8-(3-hydroxy-1H-pyrazol-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644841	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644841&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399946	490947103							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365359	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC(O)C2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O5S/c1-30(2)17-20-5-4-15-33-23-6-3-7-26(34-23)45(42,43)37-29(41)21-8-9-24(35-28(21)38(30)18-20)39-16-10-25(36-39)44-19-22(40)27-31(11-12-31)32(27)13-14-32/h3,6-10,16,20,22,27,40H,4-5,11-15,17-19H2,1-2H3,(H,33,34)(H,37,41)	IURKAXCXWULMDS-UHFFFAOYSA-N	644842	US11866450, Compound 257::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}-2-hydroxyethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644842	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644842&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400219	490947104							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365360	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC(=O)C2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H37N7O5S/c1-30(2)17-20-5-4-15-33-23-6-3-7-26(34-23)45(42,43)37-29(41)21-8-9-24(35-28(21)38(30)18-20)39-16-10-25(36-39)44-19-22(40)27-31(11-12-31)32(27)13-14-32/h3,6-10,16,20,27H,4-5,11-15,17-19H2,1-2H3,(H,33,34)(H,37,41)	JAGVNVPSZIGTKD-UHFFFAOYSA-N	644843	US11866450, Compound 258::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}-2-oxoethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644843	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644843&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399736	490947105							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365361	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC(O)CC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)15-19-5-4-13-34-22-6-3-7-25(35-22)46(43,44)38-27(42)21-8-9-23(36-26(21)39(28)17-19)40-14-10-24(37-40)45-18-20(41)16-29(11-12-29)30(31,32)33/h3,6-10,14,19-20,41H,4-5,11-13,15-18H2,1-2H3,(H,34,35)(H,38,42)	TZOTZHDPRLIVPJ-UHFFFAOYSA-N	644844	US11866450, Compound 259::Preparation of (14S)-8-(3-{2-hydroxy-3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644844	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644844&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399959	490947106							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365362	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1nc(NCCC2)ccc1O)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O5S/c1-30(2)18-20-4-3-15-33-24-7-6-22(40)29(34-24)45(42,43)37-28(41)21-5-8-25(35-27(21)38(30)19-20)39-16-9-26(36-39)44-17-10-23-31(11-12-31)32(23)13-14-32/h5-9,16,20,23,40H,3-4,10-15,17-19H2,1-2H3,(H,33,34)(H,37,41)	BDPYZBJEGVZRKG-UHFFFAOYSA-N	644845	US11866450, Compound 260::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-22-hydroxy-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644845	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644845&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400198	490947107							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365363	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1nc(NCCC2)ccc1O)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)17-19-5-3-14-34-22-8-7-21(41)27(35-22)46(43,44)38-26(42)20-6-9-23(36-25(20)39(28)18-19)40-15-10-24(37-40)45-16-4-11-29(12-13-29)30(31,32)33/h6-10,15,19,41H,3-5,11-14,16-18H2,1-2H3,(H,34,35)(H,38,42)	LXICLUDGSZXXDP-UHFFFAOYSA-N	644846	US11866450, Compound 261::Preparation of (14S)-22-hydroxy-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644846	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644846&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399999	490947108							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365364	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=N)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H35F3N8O3S/c1-27(2)17-19-5-4-14-34-21-6-3-7-24(35-21)44(33,42)38-26(41)20-8-9-22(36-25(20)39(27)18-19)40-15-10-23(37-40)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H2,33,38,41,42)	OWXMDJWCHRUTLT-UHFFFAOYSA-N	644847	US11866450, Compound 263::US11866450, Compound 262	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644847	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644847&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399966	490947109							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365365	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=N)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H35F3N8O3S/c1-27(2)17-19-5-4-14-34-21-6-3-7-24(35-21)44(33,42)38-26(41)20-8-9-22(36-25(20)39(27)18-19)40-15-10-23(37-40)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H2,33,38,41,42)	OWXMDJWCHRUTLT-UHFFFAOYSA-N	644847	US11866450, Compound 263::US11866450, Compound 262	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644847	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644847&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399966	490947109							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365366	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cc(O)cc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O5S/c1-30(2)18-20-4-3-13-33-24-16-21(40)17-27(34-24)45(42,43)37-29(41)22-5-6-25(35-28(22)38(30)19-20)39-14-7-26(36-39)44-15-8-23-31(9-10-31)32(23)11-12-32/h5-7,14,16-17,20,23H,3-4,8-13,15,18-19H2,1-2H3,(H,37,41)(H2,33,34,40)	HWTYQEVMPFJWHK-UHFFFAOYSA-N	644849	US11866450, Compound 264::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-21-hydroxy-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5,7,9,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644849	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644849&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400290	490947110							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365367	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cc(O)cc(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)17-19-5-3-12-34-22-15-20(41)16-25(35-22)46(43,44)38-27(42)21-6-7-23(36-26(21)39(28)18-19)40-13-8-24(37-40)45-14-4-9-29(10-11-29)30(31,32)33/h6-8,13,15-16,19H,3-5,9-12,14,17-18H2,1-2H3,(H,38,42)(H2,34,35,41)	KZZSBCFUTZQZHP-UHFFFAOYSA-N	644850	US11866450, Compound 265::Preparation of (14S)-21-hydroxy-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644850	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644850&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400028	490947111							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365368	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=N)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H35F3N8O3S/c1-27(2)17-19-5-4-14-34-21-6-3-7-24(35-21)44(33,42)38-26(41)20-8-9-22(36-25(20)39(27)18-19)40-15-10-23(37-40)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H2,33,38,41,42)	OWXMDJWCHRUTLT-UHFFFAOYSA-N	644851	US11866450, Compound 267::US11866450, Compound 271::US11866450, Compound 272::US11866450, Compound 266	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644851&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400206	490947112							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365369	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=N)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H35F3N8O3S/c1-27(2)17-19-5-4-14-34-21-6-3-7-24(35-21)44(33,42)38-26(41)20-8-9-22(36-25(20)39(27)18-19)40-15-10-23(37-40)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H2,33,38,41,42)	OWXMDJWCHRUTLT-UHFFFAOYSA-N	644851	US11866450, Compound 267::US11866450, Compound 271::US11866450, Compound 272::US11866450, Compound 266	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644851&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400206	490947112							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365370	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1cccc(OCCC2(CC2)C(F)(F)F)c1=O |r|	InChI=1S/C31H35F3N6O5S/c1-29(2)18-20-6-4-15-35-23-8-3-9-25(36-23)46(43,44)38-27(41)21-10-11-24(37-26(21)40(29)19-20)39-16-5-7-22(28(39)42)45-17-14-30(12-13-30)31(32,33)34/h3,5,7-11,16,20H,4,6,12-15,17-19H2,1-2H3,(H,35,36)(H,38,41)	JMQIXKOEDOLLBD-UHFFFAOYSA-N	644853	US11866450, Compound 268::Preparation of (14S)-12,12-dimethyl-8-(2-oxo-3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1,2-dihydropyridin-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaaza tetracyclo[17.3.1.111,14.05,10]tetracosa-1(23),5(10),6,8,19,21-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644853	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644853&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400106	490947113							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365371	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(CCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C31H38F3N7O3S/c1-29(2)19-21-7-6-17-35-24-9-5-10-26(36-24)45(43,44)39-28(42)23-11-12-25(37-27(23)40(29)20-21)41-18-13-22(38-41)8-3-4-14-30(15-16-30)31(32,33)34/h5,9-13,18,21H,3-4,6-8,14-17,19-20H2,1-2H3,(H,35,36)(H,39,42)	YUBLHWYVKLUISI-UHFFFAOYSA-N	644854	US11866450, Compound 269::Preparation of (14S)-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl)cyclopropyl]-3,3-dideuterio-propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaene-2,2,4-trione 	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644854	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644854&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			171034259	490947114							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365372	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-4-15-34-22-7-3-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-5-12-29(13-14-29)30(31,32)33/h3,7-11,16,20H,4-6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	GKMTUBDABPEEBO-UHFFFAOYSA-N	644748	US11866450, Compound 270::US11866450, Compound 292::Preparation of (14S)-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl) cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 287::US11866450, Compound 161	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644748&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399822	490947036							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365373	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=N)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H35F3N8O3S/c1-27(2)17-19-5-4-14-34-21-6-3-7-24(35-21)44(33,42)38-26(41)20-8-9-22(36-25(20)39(27)18-19)40-15-10-23(37-40)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H2,33,38,41,42)	OWXMDJWCHRUTLT-UHFFFAOYSA-N	644851	US11866450, Compound 267::US11866450, Compound 271::US11866450, Compound 272::US11866450, Compound 266	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644851&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400206	490947112							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365374	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=N)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H35F3N8O3S/c1-27(2)17-19-5-4-14-34-21-6-3-7-24(35-21)44(33,42)38-26(41)20-8-9-22(36-25(20)39(27)18-19)40-15-10-23(37-40)43-16-13-28(11-12-28)29(30,31)32/h3,6-10,15,19H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H2,33,38,41,42)	OWXMDJWCHRUTLT-UHFFFAOYSA-N	644851	US11866450, Compound 267::US11866450, Compound 271::US11866450, Compound 272::US11866450, Compound 266	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644851&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400206	490947112							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365375	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1	InChI=1S/C27H32F3N7O4S/c1-25(2)16-18-6-12-35-13-8-22(33-35)42(39,40)34-24(38)19-4-5-20(31-23(19)36(25)17-18)37-14-7-21(32-37)41-15-3-9-26(10-11-26)27(28,29)30/h4-5,7-8,13-14,18H,3,6,9-12,15-17H2,1-2H3,(H,34,38)	OPFQDYXJUVLFBN-UHFFFAOYSA-N	644858	Preparation of 19,19-dimethyl-4-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,21-pentaazatetracyclo[15.2.1.111,14.02,7]henicosa-2,4,6,11(21),12-pentaene-8,10,10-trione ::US11866450, Compound 273	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644858	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644858&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400160	490947115							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365376	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365377	CC1(C)CC2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H36F3N7O4S/c1-27(2)18-20-6-3-4-14-37-15-10-24(35-37)44(41,42)36-26(40)21-7-8-22(33-25(21)38(27)19-20)39-16-9-23(34-39)43-17-5-11-28(12-13-28)29(30,31)32/h7-10,15-16,20H,3-6,11-14,17-19H2,1-2H3,(H,36,40)	IWGKPJAOAOUCKN-UHFFFAOYSA-N	644860	Preparation of 21,21-dimethyl-4-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,23-pentaazatetracyclo[17.2.1.111,14.02,7]tricosa-2,4,6,11(23),12-pentaene-8,10,10-trione ::US11866450, Compound 275	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644860	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644860&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400116	490947116							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365378	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H36F3N7O4S/c1-27(2)18-20-6-3-4-14-37-15-10-24(35-37)44(41,42)36-26(40)21-7-8-22(33-25(21)38(27)19-20)39-16-9-23(34-39)43-17-5-11-28(12-13-28)29(30,31)32/h7-10,15-16,20H,3-6,11-14,17-19H2,1-2H3,(H,36,40)	IWGKPJAOAOUCKN-UHFFFAOYSA-N	644861	US11866450, Compound 277::US11866450, Compound 276	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644861	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644861&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400117	490947117							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365379	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C29H36F3N7O4S/c1-27(2)18-20-6-3-4-14-37-15-10-24(35-37)44(41,42)36-26(40)21-7-8-22(33-25(21)38(27)19-20)39-16-9-23(34-39)43-17-5-11-28(12-13-28)29(30,31)32/h7-10,15-16,20H,3-6,11-14,17-19H2,1-2H3,(H,36,40)	IWGKPJAOAOUCKN-UHFFFAOYSA-N	644861	US11866450, Compound 277::US11866450, Compound 276	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644861	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644861&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400117	490947117							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365380	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H32F3N7O4S/c1-25(2)16-18-6-12-35-13-8-22(33-35)42(39,40)34-24(38)19-4-5-20(31-23(19)36(25)17-18)37-14-7-21(32-37)41-15-3-9-26(10-11-26)27(28,29)30/h4-5,7-8,13-14,18H,3,6,9-12,15-17H2,1-2H3,(H,34,38)	OPFQDYXJUVLFBN-UHFFFAOYSA-N	644863	Preparation of 19,19-dimethyl-4-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,21-pentaazatetracyclo[15.2.1.111,14.02,7]henicosa-2,4,6,11(21),12-pentaene-8,10,10-trione::US11866450, Compound 279::US11866450, Compound 278	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644863	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644863&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			153422417	490947118							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365381	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C27H32F3N7O4S/c1-25(2)16-18-6-12-35-13-8-22(33-35)42(39,40)34-24(38)19-4-5-20(31-23(19)36(25)17-18)37-14-7-21(32-37)41-15-3-9-26(10-11-26)27(28,29)30/h4-5,7-8,13-14,18H,3,6,9-12,15-17H2,1-2H3,(H,34,38)	OPFQDYXJUVLFBN-UHFFFAOYSA-N	644863	Preparation of 19,19-dimethyl-4-(3-{3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-10&#955;6-thia-1,3,9,14,21-pentaazatetracyclo[15.2.1.111,14.02,7]henicosa-2,4,6,11(21),12-pentaene-8,10,10-trione::US11866450, Compound 279::US11866450, Compound 278	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644863	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644863&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			153422417	490947118							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365382	Cc1c2cnn1CCCC1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCC(C)(C)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H34F3N7O4S/c1-17-20-14-31-36(17)11-6-7-18-13-26(4,5)35(15-18)23-19(24(38)34-42(20,39)40)8-9-21(32-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,14,18H,6-7,11,13,15-16H2,1-5H3,(H,34,38)	LADSAPJJLSYYKT-UHFFFAOYSA-N	644865	US11866450, Compound 280	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644865	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644865&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400317	490947119							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365383	Cc1nn2CCCC3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCC(C)(C)C(F)(F)F)n1)C(C)(C)C3	InChI=1S/C27H34F3N7O4S/c1-17-20-15-35(32-17)11-6-7-18-13-26(4,5)36(14-18)23-19(24(38)34-42(20,39)40)8-9-21(31-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,15,18H,6-7,11,13-14,16H2,1-5H3,(H,34,38)	IGANITRDAXOMSK-UHFFFAOYSA-N	644866	US11866450, Compound 281	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644866	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644866&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400005	490947120							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365384	Cc1nn2CCCC3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2C)-n1ccc(OCC(C)(C)C(F)(F)F)n1)C(C)(C)C3	InChI=1S/C28H36F3N7O4S/c1-17-23-18(2)37(33-17)12-7-8-19-14-27(5,6)36(15-19)24-20(25(39)35-43(23,40)41)9-10-21(32-24)38-13-11-22(34-38)42-16-26(3,4)28(29,30)31/h9-11,13,19H,7-8,12,14-16H2,1-6H3,(H,35,39)	CKBYEJOKHOLJSA-UHFFFAOYSA-N	644867	Preparation of 20,20,22-trimethyl-4-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-10&#955;6-thia-1,3,9,13,14-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2,4,6,11(22),12-pentaene-8,10,10-trione::US11866450, Compound 282	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644867	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644867&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400309	490947121							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365385	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OC[C@@H](O)CC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)15-19-5-4-13-34-22-6-3-7-25(35-22)46(43,44)38-27(42)21-8-9-23(36-26(21)39(28)17-19)40-14-10-24(37-40)45-18-20(41)16-29(11-12-29)30(31,32)33/h3,6-10,14,19-20,41H,4-5,11-13,15-18H2,1-2H3,(H,34,35)(H,38,42)	TZOTZHDPRLIVPJ-UHFFFAOYSA-N	644868	Preparation of (14S)-8-(3-{2-hydroxy-3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaene-2,2,4-trione::US11866450, Compound 284::US11866450, Compound 283	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644868	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644868&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400331	490947122							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365386	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OC[C@@H](O)CC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)15-19-5-4-13-34-22-6-3-7-25(35-22)46(43,44)38-27(42)21-8-9-23(36-26(21)39(28)17-19)40-14-10-24(37-40)45-18-20(41)16-29(11-12-29)30(31,32)33/h3,6-10,14,19-20,41H,4-5,11-13,15-18H2,1-2H3,(H,34,35)(H,38,42)	TZOTZHDPRLIVPJ-UHFFFAOYSA-N	644868	Preparation of (14S)-8-(3-{2-hydroxy-3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaene-2,2,4-trione::US11866450, Compound 284::US11866450, Compound 283	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644868	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644868&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400331	490947122							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365387	Cc1c2cnn1CCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCC(C)(C)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C27H34F3N7O4S/c1-17-20-14-31-36(17)11-6-7-18-13-26(4,5)35(15-18)23-19(24(38)34-42(20,39)40)8-9-21(32-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,14,18H,6-7,11,13,15-16H2,1-5H3,(H,34,38)	LADSAPJJLSYYKT-UHFFFAOYSA-N	644870	US11866450, Compound 286::US11866450, Compound 288::US11866450, Compound 289::US11866450, Compound 285	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644870	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644870&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400232	490947123							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365388	Cc1c2cnn1CCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCC(C)(C)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C27H34F3N7O4S/c1-17-20-14-31-36(17)11-6-7-18-13-26(4,5)35(15-18)23-19(24(38)34-42(20,39)40)8-9-21(32-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,14,18H,6-7,11,13,15-16H2,1-5H3,(H,34,38)	LADSAPJJLSYYKT-UHFFFAOYSA-N	644870	US11866450, Compound 286::US11866450, Compound 288::US11866450, Compound 289::US11866450, Compound 285	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644870	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644870&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400232	490947123							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365389	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-4-15-34-22-7-3-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-5-12-29(13-14-29)30(31,32)33/h3,7-11,16,20H,4-6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	GKMTUBDABPEEBO-UHFFFAOYSA-N	644748	US11866450, Compound 270::US11866450, Compound 292::Preparation of (14S)-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl) cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 287::US11866450, Compound 161	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644748&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399822	490947036							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365390	Cc1c2cnn1CCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCC(C)(C)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C27H34F3N7O4S/c1-17-20-14-31-36(17)11-6-7-18-13-26(4,5)35(15-18)23-19(24(38)34-42(20,39)40)8-9-21(32-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,14,18H,6-7,11,13,15-16H2,1-5H3,(H,34,38)	LADSAPJJLSYYKT-UHFFFAOYSA-N	644870	US11866450, Compound 286::US11866450, Compound 288::US11866450, Compound 289::US11866450, Compound 285	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644870	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644870&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400232	490947123							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365391	Cc1c2cnn1CCC[C@H]1CN(c3nc(ccc3C(=O)NS2(=O)=O)-n2ccc(OCC(C)(C)C(F)(F)F)n2)C(C)(C)C1 |r|	InChI=1S/C27H34F3N7O4S/c1-17-20-14-31-36(17)11-6-7-18-13-26(4,5)35(15-18)23-19(24(38)34-42(20,39)40)8-9-21(32-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,14,18H,6-7,11,13,15-16H2,1-5H3,(H,34,38)	LADSAPJJLSYYKT-UHFFFAOYSA-N	644870	US11866450, Compound 286::US11866450, Compound 288::US11866450, Compound 289::US11866450, Compound 285	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644870	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644870&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400232	490947123							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365392	Cc1nn2CCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCC(C)(C)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C27H34F3N7O4S/c1-17-20-15-35(32-17)11-6-7-18-13-26(4,5)36(14-18)23-19(24(38)34-42(20,39)40)8-9-21(31-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,15,18H,6-7,11,13-14,16H2,1-5H3,(H,34,38)	IGANITRDAXOMSK-UHFFFAOYSA-N	644875	US11866450, Compound 291::US11866450, Compound 290	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644875	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644875&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400302	490947124							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365393	Cc1nn2CCC[C@H]3CN(c4nc(ccc4C(=O)NS(=O)(=O)c1c2)-n1ccc(OCC(C)(C)C(F)(F)F)n1)C(C)(C)C3 |r|	InChI=1S/C27H34F3N7O4S/c1-17-20-15-35(32-17)11-6-7-18-13-26(4,5)36(14-18)23-19(24(38)34-42(20,39)40)8-9-21(31-23)37-12-10-22(33-37)41-16-25(2,3)27(28,29)30/h8-10,12,15,18H,6-7,11,13-14,16H2,1-5H3,(H,34,38)	IGANITRDAXOMSK-UHFFFAOYSA-N	644875	US11866450, Compound 291::US11866450, Compound 290	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644875	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644875&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400302	490947124							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365394	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O4S/c1-28(2)18-20-6-4-15-34-22-7-3-8-25(35-22)45(42,43)38-27(41)21-9-10-23(36-26(21)39(28)19-20)40-16-11-24(37-40)44-17-5-12-29(13-14-29)30(31,32)33/h3,7-11,16,20H,4-6,12-15,17-19H2,1-2H3,(H,34,35)(H,38,41)	GKMTUBDABPEEBO-UHFFFAOYSA-N	644748	US11866450, Compound 270::US11866450, Compound 292::Preparation of (14S)-12,12-dimethyl-8-(3-{3-[1-(trifluoromethyl) cyclopropyl]propoxy}-1H-pyrazol-1-yl)-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 287::US11866450, Compound 161	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644748&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399822	490947036							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365395	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OC[C@@H](O)C2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O5S/c1-30(2)17-20-5-4-15-33-23-6-3-7-26(34-23)45(42,43)37-29(41)21-8-9-24(35-28(21)38(30)18-20)39-16-10-25(36-39)44-19-22(40)27-31(11-12-31)32(27)13-14-32/h3,6-10,16,20,22,27,40H,4-5,11-15,17-19H2,1-2H3,(H,33,34)(H,37,41)	IURKAXCXWULMDS-UHFFFAOYSA-N	644878	US11866450, Compound 294::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}-2-hydroxyethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (Diastereomer 1) (Compound 294) and (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}-2-hydroxyethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (Diastereomer 2) ::US11866450, Compound 293	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644878	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644878&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400336	490947125							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365396	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OC[C@@H](O)C2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O5S/c1-30(2)17-20-5-4-15-33-23-6-3-7-26(34-23)45(42,43)37-29(41)21-8-9-24(35-28(21)38(30)18-20)39-16-10-25(36-39)44-19-22(40)27-31(11-12-31)32(27)13-14-32/h3,6-10,16,20,22,27,40H,4-5,11-15,17-19H2,1-2H3,(H,33,34)(H,37,41)	IURKAXCXWULMDS-UHFFFAOYSA-N	644878	US11866450, Compound 294::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}-2-hydroxyethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (Diastereomer 1) (Compound 294) and (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}-2-hydroxyethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione (Diastereomer 2) ::US11866450, Compound 293	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				 2000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644878	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644878&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400336	490947125							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365397	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC(O)C2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)17-19-5-4-14-34-22-6-3-7-25(35-22)46(43,44)38-27(42)20-8-9-23(36-26(20)39(28)18-19)40-15-10-24(37-40)45-16-11-21(41)29(12-13-29)30(31,32)33/h3,6-10,15,19,21,41H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H,38,42)	WMZSCLGWSZWIAY-UHFFFAOYSA-N	644880	Preparation of (14S)-8-(3-{3-hydroxy-3-[1-(trifluoromethyl)cyclopropyl]propoxy}-1H-pyrazol-1-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 295	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644880	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644880&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400012	490947126							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365398	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC[C@@H](O)C2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)17-19-5-4-14-34-22-6-3-7-25(35-22)46(43,44)38-27(42)20-8-9-23(36-26(20)39(28)18-19)40-15-10-24(37-40)45-16-11-21(41)29(12-13-29)30(31,32)33/h3,6-10,15,19,21,41H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H,38,42)	WMZSCLGWSZWIAY-UHFFFAOYSA-N	644881	US11866450, Compound 297::US11866450, Compound 296	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644881&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400310	490947127							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365399	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCC[C@@H](O)C2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C30H36F3N7O5S/c1-28(2)17-19-5-4-14-34-22-6-3-7-25(35-22)46(43,44)38-27(42)20-8-9-23(36-26(20)39(28)18-19)40-15-10-24(37-40)45-16-11-21(41)29(12-13-29)30(31,32)33/h3,6-10,15,19,21,41H,4-5,11-14,16-18H2,1-2H3,(H,34,35)(H,38,42)	WMZSCLGWSZWIAY-UHFFFAOYSA-N	644881	US11866450, Compound 297::US11866450, Compound 296	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644881&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400310	490947127							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365400	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365401	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365402	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H39N7O4S/c1-30(2)19-21-5-4-16-33-24-6-3-7-27(34-24)44(41,42)37-29(40)22-8-9-25(35-28(22)38(30)20-21)39-17-10-26(36-39)43-18-11-23-31(12-13-31)32(23)14-15-32/h3,6-10,17,21,23H,4-5,11-16,18-20H2,1-2H3,(H,33,34)(H,37,40)	VCSUIBJKYCVWNF-UHFFFAOYSA-N	644782	US11866450, Compound 301::US11866450, Compound 253::US11866450, Compound 298::Preparation of (14S)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 300::US11866450, Compound 252::US11866450, Compound 274::US11866450, Compound 195	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644782&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139399801	490947061							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365403	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccn(CCO2)n1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1 |r|	InChI=1S/C26H30F3N7O5S/c1-24(2)15-17-16-35(24)22-18(23(37)33-42(38,39)21-6-10-34(32-21)12-14-40-17)3-4-19(30-22)36-11-5-20(31-36)41-13-9-25(7-8-25)26(27,28)29/h3-6,10-11,17H,7-9,12-16H2,1-2H3,(H,33,37)	OEVMKEKULSFZIY-UHFFFAOYSA-N	644754	US11866450, Compound 302::Preparation of 20,20-dimethyl-4-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-17-oxa-10&#955;6-thia-1,3,9,14,22-pentaazatetracyclo[16.2.1.111,14.02,7]docosa-2(7),3,5,11(22),12-pentaene-8,10,10-trione::US11866450, Compound 167	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644754	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644754&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400172	490947040							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365404	CC1(C)C[C@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCCC2)n1)C1=CCCCO1 |r,t:33|	InChI=1S/C25H31N5O4S/c1-25(2)15-17-7-6-13-26-21-9-5-10-22(28-21)35(32,33)29-24(31)18-11-12-19(20-8-3-4-14-34-20)27-23(18)30(25)16-17/h5,8-12,17H,3-4,6-7,13-16H2,1-2H3,(H,26,28)(H,29,31)	TUQDVFPSCJVGGJ-UHFFFAOYSA-N	644887	Preparation of (14S)-8-(3,4-dihydro-2H-pyran-6-yl)-12,12-dimethyl-2&#955;6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione ::US11866450, Compound 303	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644887	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644887&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400131	490947128							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365405	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC(F)(F)C2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H37F2N7O4S/c1-29(2)16-20-17-32(33,34)19-35-23-4-3-5-26(36-23)46(43,44)39-28(42)21-6-7-24(37-27(21)40(29)18-20)41-14-8-25(38-41)45-15-9-22-30(10-11-30)31(22)12-13-31/h3-8,14,20,22H,9-13,15-19H2,1-2H3,(H,35,36)(H,39,42)	XOEATPPWEQBTDO-UHFFFAOYSA-N	644888	US11866450, Compound 305::US11866450, Compound 304	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644888	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644888&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400305	490947129							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365406	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NCC(F)(F)C2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H37F2N7O4S/c1-29(2)16-20-17-32(33,34)19-35-23-4-3-5-26(36-23)46(43,44)39-28(42)21-6-7-24(37-27(21)40(29)18-20)41-14-8-25(38-41)45-15-9-22-30(10-11-30)31(22)12-13-31/h3-8,14,20,22H,9-13,15-19H2,1-2H3,(H,35,36)(H,39,42)	XOEATPPWEQBTDO-UHFFFAOYSA-N	644888	US11866450, Compound 305::US11866450, Compound 304	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644888	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644888&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400305	490947129							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365407	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC[C@H](F)C2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H38FN7O4S/c1-30(2)17-20-16-21(33)18-34-24-4-3-5-27(35-24)45(42,43)38-29(41)22-6-7-25(36-28(22)39(30)19-20)40-14-8-26(37-40)44-15-9-23-31(10-11-31)32(23)12-13-32/h3-8,14,20-21,23H,9-13,15-19H2,1-2H3,(H,34,35)(H,38,41)	RTMSDIOARGJXBA-UHFFFAOYSA-N	644890	US11866450, Compound 307::US11866450, Compound 308::US11866450, Compound 309::US11866450, Compound 306	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644890	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644890&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400203	490947130							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365408	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC[C@H](F)C2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H38FN7O4S/c1-30(2)17-20-16-21(33)18-34-24-4-3-5-27(35-24)45(42,43)38-29(41)22-6-7-25(36-28(22)39(30)19-20)40-14-8-26(37-40)44-15-9-23-31(10-11-31)32(23)12-13-32/h3-8,14,20-21,23H,9-13,15-19H2,1-2H3,(H,34,35)(H,38,41)	RTMSDIOARGJXBA-UHFFFAOYSA-N	644890	US11866450, Compound 307::US11866450, Compound 308::US11866450, Compound 309::US11866450, Compound 306	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				>3000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644890	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644890&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400203	490947130							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365409	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC[C@H](F)C2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H38FN7O4S/c1-30(2)17-20-16-21(33)18-34-24-4-3-5-27(35-24)45(42,43)38-29(41)22-6-7-25(36-28(22)39(30)19-20)40-14-8-26(37-40)44-15-9-23-31(10-11-31)32(23)12-13-32/h3-8,14,20-21,23H,9-13,15-19H2,1-2H3,(H,34,35)(H,38,41)	RTMSDIOARGJXBA-UHFFFAOYSA-N	644890	US11866450, Compound 307::US11866450, Compound 308::US11866450, Compound 309::US11866450, Compound 306	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644890	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644890&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400203	490947130							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1365410	CC1(C)C[C@@H]2CN1c1nc(ccc1C(=O)NS(=O)(=O)c1cccc(NC[C@H](F)C2)n1)-n1ccc(OCCC2C3(CC3)C22CC2)n1 |r|	InChI=1S/C32H38FN7O4S/c1-30(2)17-20-16-21(33)18-34-24-4-3-5-27(35-24)45(42,43)38-29(41)22-6-7-25(36-28(22)39(30)19-20)40-14-8-26(37-40)44-15-9-23-31(10-11-31)32(23)12-13-32/h3-8,14,20-21,23H,9-13,15-19H2,1-2H3,(H,34,35)(H,38,41)	RTMSDIOARGJXBA-UHFFFAOYSA-N	644890	US11866450, Compound 307::US11866450, Compound 308::US11866450, Compound 309::US11866450, Compound 306	Cystic fibrosis transmembrane conductance regulator	Homo sapiens				<1000					US Patent		10.7270/Q2RV0SW7		aid1920163	US11866450	Clemens, JJ; Abela, AR; Anderson, CD; Busch, BB; Chen, WG; Cleveland, T; Coon, TR; Frieman, B; Ghirmai, SG; Grootenhuis, P; Gulevich, AV; Hadida Ruah, SS; Hsia, CK; Kang, P; Khatuya, H; McCartney, J; Miller, MT; Paraselli, P; Pierre, F; Swift, SE; Termin, A; Uy, J; Vogel, CV; Zhou, J	1/9/2024	3/2/2024	Vertex Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=644890	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8455&target=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=644890&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator&column=ki&startPg=0&Increment=50&submit=Search			139400203	490947130							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	5UAK,9DW7,9DW5,9DW4,7SVR,8FZQ,2BBO,1XMJ	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102